{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:51:36Z","timestamp":1792623096979,"version":"4.5.0"},"reference-count":241,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT155922"],"award-info":[{"award-number":["PJT155922"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL159159"],"award-info":[{"award-number":["1R01HL159159"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL171284"],"award-info":[{"award-number":["R01HL171284"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011906","name":"Joe Niekro Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011906","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-18-1-0351"],"award-info":[{"award-number":["W81XWH-18-1-0351"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Brain arteriovenous malformations are abnormal vascular structures in which an artery shunts high pressure blood directly to a vein without an intervening capillary bed. These lesions become highly remodeled over time and are prone to rupture. Historically, brain arteriovenous malformations have been challenging to treat, using primarily surgical approaches. Over the past few decades, the genetic causes of these malformations have been uncovered. These can be divided into (1) familial forms, such as loss of function mutations in TGF-\u03b2 (BMP9\/10) components in hereditary hemorrhagic telangiectasia, or (2) sporadic forms, resulting from somatic gain of function mutations in genes involved in the RAS-MAPK signaling pathway. Leveraging these genetic discoveries, preclinical mouse models have been developed to uncover the mechanisms underlying abnormal vessel formation, and thus revealing potential therapeutic targets. Impressively, initial preclinical studies suggest that pharmacological treatments disrupting these aberrant pathways may ameliorate the abnormal pathologic vessel remodeling and inflammatory and hemorrhagic nature of these high-flow vascular anomalies. Intriguingly, these studies also suggest uncontrolled angiogenic signaling may be a major driver in bAVM pathogenesis. This comprehensive review describes the genetics underlying both inherited and sporadic bAVM and details the state of the field regarding murine models of bAVM, highlighting emerging therapeutic targets that may transform our approach to treating these devastating lesions.<\/jats:p>","DOI":"10.1007\/s10456-024-09953-5","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T14:05:06Z","timestamp":1738591506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["From bench to bedside: murine models of inherited and sporadic brain arteriovenous malformations"],"prefix":"10.1007","volume":"28","author":[{"given":"Ashely R.","family":"Ricciardelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael","family":"Genet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiisha","family":"Genet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Samuel T.","family":"McClugage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Hirschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3225-2937","authenticated-orcid":false,"given":"Joshua D.","family":"Wythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"3","key":"9953_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/02688697.2018.1478060","volume":"32","author":"A Dalton","year":"2018","unstructured":"Dalton A, Dobson G, Prasad M, Mukerji N (2018) De novo intracerebral arteriovenous malformations and a review of the theories of their formation. Br J Neurosurg 32(3):305\u2013311. https:\/\/doi.org\/10.1080\/02688697.2018.1478060","journal-title":"Br J Neurosurg"},{"key":"9953_CR2","doi-asserted-by":"publisher","first-page":"b3016","DOI":"10.1136\/bmj.b3016","volume":"339","author":"Z Morris","year":"2009","unstructured":"Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, Alphs H, Ladd SC, Warlow C, Wardlaw JM, Al-Shahi Salman R (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 339:b3016. https:\/\/doi.org\/10.1136\/bmj.b3016","journal-title":"BMJ"},{"issue":"1","key":"9953_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/STROKEAHA.109.566018","volume":"41","author":"RA Gabriel","year":"2010","unstructured":"Gabriel RA, Kim H, Sidney S, McCulloch CE, Singh V, Johnston SC, Ko NU, Achrol AS, Zaroff JG, Young WL (2010) Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke 41(1):21\u201326. https:\/\/doi.org\/10.1161\/STROKEAHA.109.566018","journal-title":"Stroke"},{"issue":"6","key":"9953_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/s0387-7604(03)00029-9","volume":"25","author":"AD Meyer-Heim","year":"2003","unstructured":"Meyer-Heim AD, Boltshauser E (2003) Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev 25(6):416\u2013421. https:\/\/doi.org\/10.1016\/s0387-7604(03)00029-9","journal-title":"Brain Dev"},{"issue":"1","key":"9953_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0090-3019(84)90227-1","volume":"22","author":"P Celli","year":"1984","unstructured":"Celli P, Ferrante L, Palma L, Cavedon G (1984) Cerebral arteriovenous malformations in children: clinical features and outcome of treatment in children and in adults. Surg Neurol 22(1):43\u201349. https:\/\/doi.org\/10.1016\/0090-3019(84)90227-1","journal-title":"Surg Neurol"},{"key":"9953_CR6","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/nrdp.2015.8","volume":"1","author":"MT Lawton","year":"2015","unstructured":"Lawton MT, Rutledge WC, Kim H, Stapf C, Whitehead KJ, Li DY, Krings T, terBrugge K, Kondziolka D, Morgan MK, Moon K, Spetzler RF (2015) Brain arteriovenous malformations. Nat Rev Dis Primers 1:15008. https:\/\/doi.org\/10.1038\/nrdp.2015.8","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"9953_CR7","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1161\/STROKEAHA.107.485573","volume":"38","author":"H Kim","year":"2007","unstructured":"Kim H, Sidney S, McCulloch CE, Poon KY, Singh V, Johnston SC, Ko NU, Achrol AS, Lawton MT, Higashida RT et al (2007) Racial\/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke 38(9):2430\u20132437. https:\/\/doi.org\/10.1161\/STROKEAHA.107.485573","journal-title":"Stroke"},{"issue":"5","key":"9953_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12975-014-0351-0","volume":"5","author":"WC Rutledge","year":"2014","unstructured":"Rutledge WC, Ko NU, Lawton MT, Kim H (2014) Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res 5(5):538\u2013542. https:\/\/doi.org\/10.1007\/s12975-014-0351-0","journal-title":"Transl Stroke Res"},{"issue":"9","key":"9953_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1212\/01.wnl.0000210524.68507.87","volume":"66","author":"C Stapf","year":"2006","unstructured":"Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP (2006) Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 66(9):1350\u20131355. https:\/\/doi.org\/10.1212\/01.wnl.0000210524.68507.87","journal-title":"Neurology"},{"issue":"5","key":"9953_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3171\/JNS-07\/11\/0965","volume":"107","author":"S Yamada","year":"2007","unstructured":"Yamada S, Takagi Y, Nozaki K, Kikuta K, Hashimoto N (2007) Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg 107(5):965\u2013972. https:\/\/doi.org\/10.3171\/JNS-07\/11\/0965","journal-title":"J Neurosurg"},{"issue":"5","key":"9953_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1227\/01.NEU.0000330401.82582.5E","volume":"63","author":"JA Hernesniemi","year":"2008","unstructured":"Hernesniemi JA, Dashti R, Juvela S, Vaart K, Niemela M, Laakso A (2008) Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 63(5):823\u2013829. https:\/\/doi.org\/10.1227\/01.NEU.0000330401.82582.5E","journal-title":"Neurosurgery"},{"issue":"7","key":"9953_CR12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1212\/WNL.0000000000000688","volume":"83","author":"H Kim","year":"2014","unstructured":"Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL, Coinvestigators M (2014) Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology 83(7):590\u2013597. https:\/\/doi.org\/10.1212\/WNL.0000000000000688","journal-title":"Neurology"},{"issue":"5","key":"9953_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1227\/00006123-198411000-00003","volume":"15","author":"D Fults","year":"1984","unstructured":"Fults D, Kelly DL Jr (1984) Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery 15(5):658\u2013662. https:\/\/doi.org\/10.1227\/00006123-198411000-00003","journal-title":"Neurosurgery"},{"issue":"Pt 2","key":"9953_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/brain\/awn318","volume":"132","author":"J van Beijnum","year":"2009","unstructured":"van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJ, Al-Shahi Salman R et al (2009) Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain 132(Pt 2):537\u2013543. https:\/\/doi.org\/10.1093\/brain\/awn318","journal-title":"Brain"},{"issue":"3","key":"9953_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3171\/jns.1988.68.3.0352","volume":"68","author":"RD Brown Jr","year":"1988","unstructured":"Brown RD Jr, Wiebers DO, Forbes G, O\u2019Fallon WM, Piepgras DG, Marsh WR, Maciunas RJ (1988) The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 68(3):352\u2013357. https:\/\/doi.org\/10.3171\/jns.1988.68.3.0352","journal-title":"J Neurosurg"},{"issue":"1","key":"9953_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3171\/2020.11.JNS203298","volume":"136","author":"JS Catapano","year":"2022","unstructured":"Catapano JS, Frisoli FA, Nguyen CL, Labib MA, Cole TS, Baranoski JF, Kim H, Spetzler RF, Lawton MT (2022) Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system. J Neurosurg 136(1):125\u2013133. https:\/\/doi.org\/10.3171\/2020.11.JNS203298","journal-title":"J Neurosurg"},{"issue":"11","key":"9953_CR17","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3390\/biomedicines11112876","volume":"11","author":"AR Ricciardelli","year":"2023","unstructured":"Ricciardelli AR, Robledo A, Fish JE, Kan PT, Harris TH, Wythe JD (2023) The role and therapeutic implications of inflammation in the pathogenesis of brain arteriovenous malformations. Biomedicines 11(11):2876. https:\/\/doi.org\/10.3390\/biomedicines11112876","journal-title":"Biomedicines"},{"issue":"1","key":"9953_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10143-023-02001-8","volume":"46","author":"P Jarvelin","year":"2023","unstructured":"Jarvelin P, Pekonen H, Koivisto T, Frosen J (2023) Recurrence of arteriovenous malformations of the brain after complete surgical resection: Kuopio University Hospital experience and systematic review of the literature. Neurosurg Rev 46(1):99. https:\/\/doi.org\/10.1007\/s10143-023-02001-8","journal-title":"Neurosurg Rev"},{"issue":"4","key":"9953_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jmg.2005.035451","volume":"43","author":"TG Letteboer","year":"2006","unstructured":"Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ (2006) Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 43(4):371\u2013377. https:\/\/doi.org\/10.1136\/jmg.2005.035451","journal-title":"J Med Genet"},{"issue":"12","key":"9953_CR20","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1161\/01.str.0000043674.99741.9b","volume":"33","author":"HT ApSimon","year":"2002","unstructured":"ApSimon HT, Reef H, Phadke RV, Popovic EA (2002) A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke 33(12):2794\u20132800. https:\/\/doi.org\/10.1161\/01.str.0000043674.99741.9b","journal-title":"Stroke"},{"issue":"12","key":"9953_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/M20-1443","volume":"173","author":"ME Faughnan","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, Deslandres E, Kasthuri RS, Lausman A, Poetker D, Ratjen F, Chesnutt MS, Clancy M, Whitehead KJ, Al-Samkari H, Chakinala M, Conrad M, Cortes D, Crocione C, Darling J, de Gussem E, Derksen C, Dupuis-Girod S, Foy P, Geisthoff U, Gossage JR, Hammill A, Heimdal K, Henderson K, Iyer VN, Kjeldsen AD, Komiyama M, Korenblatt K, McDonald J, McMahon J, McWilliams J, Meek ME, Mei-Zahav M, Olitsky S, Palmer S, Pantalone R, Piccirillo JF, Plahn B, Porteous MEM, Post MC, Radovanovic I, Rochon PJ, Rodriguez-Lopez J, Sabba C, Serra M, Shovlin C, Sprecher D, White AJ, Winship I, Zarrabeitia R (2020) Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med 173(12):989\u20131001. https:\/\/doi.org\/10.7326\/M20-1443","journal-title":"Ann Intern Med"},{"issue":"1","key":"9953_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1148\/radiol.2021203487","volume":"300","author":"SW Hetts","year":"2021","unstructured":"Hetts SW, Shieh JT, Ohliger MA, Conrad MB (2021) Hereditary hemorrhagic telangiectasia: the convergence of genotype, phenotype, and imaging in modern diagnosis and management of a multisystem disease. Radiology 300(1):17\u201330. https:\/\/doi.org\/10.1148\/radiol.2021203487","journal-title":"Radiology"},{"key":"9953_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2015.00001","volume":"6","author":"J McDonald","year":"2015","unstructured":"McDonald J, Wooderchak-Donahue W, VanSant WC, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015) Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6:1. https:\/\/doi.org\/10.3389\/fgene.2015.00001","journal-title":"Front Genet"},{"issue":"3","key":"9953_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(SICI)1096-8628(19980319)76:3<269::AID-AJMG12>3.0.CO;2-F","volume":"76","author":"DA Marchuk","year":"1998","unstructured":"Marchuk DA, Guttmacher AE, Penner JA, Ganguly P (1998) Report on the workshop on hereditary hemorrhagic telangiectasia, July 10\u201311, 1997. Am J Med Genet 76(3):269\u2013273","journal-title":"Am J Med Genet"},{"key":"9953_CR25","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/18-145","author":"T Saparia","year":"2019","unstructured":"Saparia T, Faughnan ME, Schneider JL, Almers LM, Chow N, Grosse SD, Kim H, Zaroff JG (2019) Assessing the hereditary hemorrhagic telangiectasia algorithms in a community-based patient population. Perm J. https:\/\/doi.org\/10.7812\/TPP\/18-145","journal-title":"Perm J"},{"issue":"1","key":"9953_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13023-019-1281-4","volume":"15","author":"F Robert","year":"2020","unstructured":"Robert F, Desroches-Castan A, Bailly S, Dupuis-Girod S, Feige JJ (2020) Future treatments for hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis 15(1):4. https:\/\/doi.org\/10.1186\/s13023-019-1281-4","journal-title":"Orphanet J Rare Dis"},{"key":"9953_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030487","author":"K Tzavlaki","year":"2020","unstructured":"Tzavlaki K, Moustakas A (2020) TGF-beta signaling. Biomolecules. https:\/\/doi.org\/10.3390\/biom10030487","journal-title":"Biomolecules"},{"issue":"1","key":"9953_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3121\/cmr.4.1.66","volume":"4","author":"LA Fernandez","year":"2006","unstructured":"Fernandez LA, Sanz-Rodriguez F, Blanco FJ, Bernabeu C, Botella LM (2006) Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res 4(1):66\u201378. https:\/\/doi.org\/10.3121\/cmr.4.1.66","journal-title":"Clin Med Res"},{"issue":"10","key":"9953_CR29","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1093\/hmg\/4.10.1983","volume":"4","author":"KA McAllister","year":"1995","unstructured":"McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, Guttmacher AE, Marchuk DA (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4(10):1983\u20131985. https:\/\/doi.org\/10.1093\/hmg\/4.10.1983","journal-title":"Hum Mol Genet"},{"issue":"24","key":"9953_CR30","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1007\/s00018-017-2636-4","volume":"74","author":"BL Roman","year":"2017","unstructured":"Roman BL, Hinck AP (2017) ALK1 signaling in development and disease: new paradigms. Cell Mol Life Sci 74(24):4539\u20134560. https:\/\/doi.org\/10.1007\/s00018-017-2636-4","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"9953_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/513906","volume":"61","author":"CL Shovlin","year":"1997","unstructured":"Shovlin CL, Hughes JM, Scott J, Seidman CE, Seidman JG (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61(1):68\u201379. https:\/\/doi.org\/10.1086\/513906","journal-title":"Am J Hum Genet"},{"issue":"15","key":"9953_CR32","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.1016\/S0021-9258(19)38892-1","volume":"265","author":"A Gougos","year":"1990","unstructured":"Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265(15):8361\u20138364","journal-title":"J Biol Chem"},{"issue":"2","key":"9953_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13(2):189\u2013195. https:\/\/doi.org\/10.1038\/ng0696-189","journal-title":"Nat Genet"},{"issue":"4","key":"9953_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8(4):345\u2013351. https:\/\/doi.org\/10.1038\/ng1294-345","journal-title":"Nat Genet"},{"issue":"3","key":"9953_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","volume":"93","author":"WL Wooderchak-Donahue","year":"2013","unstructured":"Wooderchak-Donahue WL, McDonald J, O\u2019Fallon B, Upton PD, Li W, Roman BL, Young S, Plant P, Fulop GT, Langa C, Morrell NW, Botella LM, Bernabeu C, Stevenson DA, Runo JR, Bayrak-Toydemir P (2013) BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93(3):530\u2013537. https:\/\/doi.org\/10.1016\/j.ajhg.2013.07.004","journal-title":"Am J Hum Genet"},{"issue":"3","key":"9953_CR36","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ajmg.a.62584","volume":"188","author":"S Balachandar","year":"2022","unstructured":"Balachandar S, Graves TJ, Shimonty A, Kerr K, Kilner J, Xiao S, Slade R, Sroya M, Alikian M, Curetean E, Thomas E, McConnell VPM, McKee S, Boardman-Pretty F, Devereau A, Fowler TA, Caulfield MJ, Alton EW, Ferguson T, Redhead J, McKnight AJ, Thomas GA et al (2022) Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. Am J Med Genet A 188(3):959\u2013964. https:\/\/doi.org\/10.1002\/ajmg.a.62584","journal-title":"Am J Med Genet A"},{"issue":"1","key":"9953_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ajmg.a.62522","volume":"188","author":"A Farhan","year":"2022","unstructured":"Farhan A, Yuan F, Partan E, Weiss CR (2022) Clinical manifestations of patients with GDF2 mutations associated with hereditary hemorrhagic telangiectasia type 5. Am J Med Genet A 188(1):199\u2013209. https:\/\/doi.org\/10.1002\/ajmg.a.62522","journal-title":"Am J Med Genet A"},{"issue":"12","key":"9953_CR38","doi-asserted-by":"publisher","first-page":"e1685","DOI":"10.1002\/mgg3.1685","volume":"9","author":"J Hodgson","year":"2021","unstructured":"Hodgson J, Ruiz-Llorente L, McDonald J, Quarrell O, Ugonna K, Bentham J, Mason R, Martin J, Moore D, Bergstrom K, Bayrak-Toydemir P, Wooderchak-Donahue W, Morrell NW, Condliffe R, Bernabeu C, Upton PD (2021) Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an \u201cHHT-like\u201d syndrome in children. Mol Genet Genomic Med 9(12):e1685. https:\/\/doi.org\/10.1002\/mgg3.1685","journal-title":"Mol Genet Genomic Med"},{"key":"9953_CR39","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1970","author":"J Liu","year":"2020","unstructured":"Liu J, Yang J, Tang X, Li H, Shen Y, Gu W, Zhao S (2020) Homozygous GDF2-related hereditary hemorrhagic telangiectasia in a Chinese family. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2019-1970","journal-title":"Pediatrics"},{"issue":"9412","key":"9953_CR40","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363(9412):852\u2013859. https:\/\/doi.org\/10.1016\/S0140-6736(04)15732-2","journal-title":"Lancet"},{"issue":"8","key":"9953_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","volume":"18","author":"N Ricard","year":"2021","unstructured":"Ricard N, Bailly S, Guignabert C, Simons M (2021) The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy. Nat Rev Cardiol 18(8):565\u2013580. https:\/\/doi.org\/10.1038\/s41569-021-00517-4","journal-title":"Nat Rev Cardiol"},{"key":"9953_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176379","author":"T Al Tabosh","year":"2024","unstructured":"Al Tabosh T, Al Tarrass M, Tourvieilhe L, Guilhem A, Dupuis-Girod S, Bailly S (2024) Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI176379","journal-title":"J Clin Invest"},{"issue":"5419","key":"9953_CR43","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.284.5419.1534","volume":"284","author":"DY Li","year":"1999","unstructured":"Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP (1999) Defective angiogenesis in mice lacking endoglin. Science 284(5419):1534\u20131537. https:\/\/doi.org\/10.1126\/science.284.5419.1534","journal-title":"Science"},{"issue":"3","key":"9953_CR44","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/81634","volume":"26","author":"LD Urness","year":"2000","unstructured":"Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26(3):328\u2013331. https:\/\/doi.org\/10.1038\/81634","journal-title":"Nat Genet"},{"issue":"1","key":"9953_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0012-1606(03)00158-1","volume":"261","author":"LK Sorensen","year":"2003","unstructured":"Sorensen LK, Brooke BS, Li DY, Urness LD (2003) Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol 261(1):235\u2013250. https:\/\/doi.org\/10.1016\/s0012-1606(03)00158-1","journal-title":"Dev Biol"},{"issue":"3","key":"9953_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/01.STR.0000056170.47815.37","volume":"34","author":"J Satomi","year":"2003","unstructured":"Satomi J, Mount RJ, Toporsian M, Paterson AD, Wallace MC, Harrison RV, Letarte M (2003) Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 34(3):783\u2013789. https:\/\/doi.org\/10.1161\/01.STR.0000056170.47815.37","journal-title":"Stroke"},{"issue":"3","key":"9953_CR47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12975-010-0020-x","volume":"1","author":"Q Hao","year":"2010","unstructured":"Hao Q, Zhu Y, Su H, Shen F, Yang GY, Kim H, Young WL (2010) VEGF induces more severe cerebrovascular dysplasia in Endoglin than in Alk1 mice. Transl Stroke Res 1(3):197\u2013201. https:\/\/doi.org\/10.1007\/s12975-010-0020-x","journal-title":"Transl Stroke Res"},{"issue":"5","key":"9953_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/hmg\/ddg050","volume":"12","author":"S Srinivasan","year":"2003","unstructured":"Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA (2003) A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12(5):473\u2013482. https:\/\/doi.org\/10.1093\/hmg\/ddg050","journal-title":"Hum Mol Genet"},{"issue":"12","key":"9953_CR49","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1161\/01.CIR.0000058170.92267.00","volume":"107","author":"E Torsney","year":"2003","unstructured":"Torsney E, Charlton R, Diamond AG, Burn J, Soames JV, Arthur HM (2003) Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Circulation 107(12):1653\u20131657. https:\/\/doi.org\/10.1161\/01.CIR.0000058170.92267.00","journal-title":"Circulation"},{"issue":"1","key":"9953_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/dbio.1999.9534","volume":"217","author":"HM Arthur","year":"2000","unstructured":"Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Burn J, Diamond AG (2000) Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217(1):42\u201353. https:\/\/doi.org\/10.1006\/dbio.1999.9534","journal-title":"Dev Biol"},{"issue":"10","key":"9953_CR51","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI8088","volume":"104","author":"A Bourdeau","year":"1999","unstructured":"Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104(10):1343\u20131351. https:\/\/doi.org\/10.1172\/JCI8088","journal-title":"J Clin Invest"},{"issue":"12","key":"9953_CR52","doi-asserted-by":"publisher","first-page":"e8283","DOI":"10.1371\/journal.pone.0008283","volume":"4","author":"R Srinivasan","year":"2009","unstructured":"Srinivasan R, Zabuawala T, Huang H, Zhang J, Gulati P, Fernandez S, Karlo JC, Landreth GE, Leone G, Ostrowski MC (2009) Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS ONE 4(12):e8283. https:\/\/doi.org\/10.1371\/journal.pone.0008283","journal-title":"PLoS ONE"},{"issue":"2","key":"9953_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/01.WCB.0000107730.66603.51","volume":"24","author":"B Xu","year":"2004","unstructured":"Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, Hashimoto T, Young WL, Yang GY (2004) Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 24(2):237\u2013244. https:\/\/doi.org\/10.1097\/01.WCB.0000107730.66603.51","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"9953_CR54","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1172\/JCI39482","volume":"119","author":"SO Park","year":"2009","unstructured":"Park SO, Wankhede M, Lee YJ, Choi EJ, Fliess N, Choe SW, Oh SH, Walter G, Raizada MK, Sorg BS, Oh SP (2009) Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119(11):3487\u20133496. https:\/\/doi.org\/10.1172\/JCI39482","journal-title":"J Clin Invest"},{"issue":"6","key":"9953_CR55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/ana.22348","volume":"69","author":"EJ Walker","year":"2011","unstructured":"Walker EJ, Su H, Shen F, Choi EJ, Oh SP, Chen G, Lawton MT, Kim H, Chen Y, Chen W, Young WL (2011) Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol 69(6):954\u2013962. https:\/\/doi.org\/10.1002\/ana.22348","journal-title":"Ann Neurol"},{"issue":"6","key":"9953_CR56","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1159\/000337762","volume":"33","author":"EJ Choi","year":"2012","unstructured":"Choi EJ, Walker EJ, Shen F, Oh SP, Arthur HM, Young WL, Su H (2012) Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis 33(6):540\u2013547. https:\/\/doi.org\/10.1159\/000337762","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"9953_CR57","doi-asserted-by":"publisher","first-page":"e88511","DOI":"10.1371\/journal.pone.0088511","volume":"9","author":"EJ Choi","year":"2014","unstructured":"Choi EJ, Chen W, Jun K, Arthur HM, Young WL, Su H (2014) Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia. PLoS ONE 9(2):e88511. https:\/\/doi.org\/10.1371\/journal.pone.0088511","journal-title":"PLoS ONE"},{"issue":"10","key":"9953_CR58","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/ATVBAHA.114.303984","volume":"34","author":"EM Garrido-Martin","year":"2014","unstructured":"Garrido-Martin EM, Nguyen HL, Cunningham TA, Choe SW, Jiang Z, Arthur HM, Lee YJ, Oh SP (2014) Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models\u2013brief report. Arterioscler Thromb Vasc Biol 34(10):2232\u20132236. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303984","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9953_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-023-09881-w","author":"L Scherschinski","year":"2023","unstructured":"Scherschinski L, Han C, Kim YH, Winkler EA, Catapano JS, Schriber TD, Vajkoczy P, Lawton MT, Oh SP (2023) Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia. Angiogenesis. https:\/\/doi.org\/10.1007\/s10456-023-09881-w","journal-title":"Angiogenesis"},{"key":"9953_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2021.6.JNS21717","volume":"137","author":"C Han","year":"2021","unstructured":"Han C, Lang MJ, Nguyen CL, Luna Melendez E, Mehta S, Turner GH, Lawton MT, Oh SP (2021) Novel experimental model of brain arteriovenous malformations using conditional Alk1 gene deletion in transgenic mice. J Neurosurg 137:1\u201312. https:\/\/doi.org\/10.3171\/2021.6.JNS21717","journal-title":"J Neurosurg"},{"issue":"5","key":"9953_CR61","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/STROKEAHA.111.647024","volume":"43","author":"I Milton","year":"2012","unstructured":"Milton I, Ouyang D, Allen CJ, Yanasak NE, Gossage JR, Alleyne CH Jr, Seki T (2012) Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations. Stroke 43(5):1432\u20131435. https:\/\/doi.org\/10.1161\/STROKEAHA.111.647024","journal-title":"Stroke"},{"issue":"3","key":"9953_CR62","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/STROKEAHA.113.003655","volume":"45","author":"W Chen","year":"2014","unstructured":"Chen W, Sun Z, Han Z, Jun K, Camus M, Wankhede M, Mao L, Arnold T, Young WL, Su H (2014) De novo cerebrovascular malformation in the adult mouse after endothelial Alk1 deletion and angiogenic stimulation. Stroke 45(3):900\u2013902. https:\/\/doi.org\/10.1161\/STROKEAHA.113.003655","journal-title":"Stroke"},{"issue":"20","key":"9953_CR63","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/j.devcel.2022.09.015","volume":"57","author":"L Muhl","year":"2022","unstructured":"Muhl L, Mocci G, Pietila R, Liu J, He L, Genove G, Leptidis S, Gustafsson S, Buyandelger B, Raschperger E, Hansson EM, Bjorkegren JLM, Vanlandewijck M, Lendahl U, Betsholtz C (2022) A single-cell transcriptomic inventory of murine smooth muscle cells. Dev Cell 57(20):2426\u20132443. https:\/\/doi.org\/10.1016\/j.devcel.2022.09.015","journal-title":"Dev Cell"},{"issue":"2","key":"9953_CR64","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1182\/blood-2007-08-107359","volume":"111","author":"SO Park","year":"2008","unstructured":"Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z, Park A, Wu X, Kaartinen V, Roman BL, Oh SP (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111(2):633\u2013642. https:\/\/doi.org\/10.1182\/blood-2007-08-107359","journal-title":"Blood"},{"issue":"6","key":"9953_CR65","doi-asserted-by":"publisher","first-page":"e98646","DOI":"10.1371\/journal.pone.0098646","volume":"9","author":"S Tual-Chalot","year":"2014","unstructured":"Tual-Chalot S, Mahmoud M, Allinson KR, Redgrave RE, Zhai Z, Oh SP, Fruttiger M, Arthur HM (2014) Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression. PLoS ONE 9(6):e98646. https:\/\/doi.org\/10.1371\/journal.pone.0098646","journal-title":"PLoS ONE"},{"issue":"8","key":"9953_CR66","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1161\/ATVBAHA.123.319385","volume":"43","author":"X Zhou","year":"2023","unstructured":"Zhou X, Pucel JC, Nomura-Kitabayashi A, Chandakkar P, Guidroz AP, Jhangiani NL, Bao D, Fan J, Arthur HM, Ullmer C, Klein C, Marambaud P, Meadows SM (2023) ANG2 blockade diminishes proangiogenic cerebrovascular defects associated with models of hereditary hemorrhagic telangiectasia. Arterioscler Thromb Vasc Biol 43(8):1384\u20131403. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319385","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"9953_CR67","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.120.053047","volume":"144","author":"H Park","year":"2021","unstructured":"Park H, Furtado J, Poulet M, Chung M, Yun S, Lee S, Sessa WC, Franco CA, Schwartz MA, Eichmann A (2021) Defective flow-migration coupling causes arteriovenous malformations in hereditary hemorrhagic telangiectasia. Circulation 144(10):805\u2013822. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.053047","journal-title":"Circulation"},{"issue":"6","key":"9953_CR68","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ncb3534","volume":"19","author":"Y Jin","year":"2017","unstructured":"Jin Y, Muhl L, Burmakin M, Wang Y, Duchez AC, Betsholtz C, Arthur HM, Jakobsson L (2017) Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nat Cell Biol 19(6):639\u2013652. https:\/\/doi.org\/10.1038\/ncb3534","journal-title":"Nat Cell Biol"},{"issue":"2","key":"9953_CR69","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCRESAHA.119.315974","volume":"126","author":"S Tual-Chalot","year":"2020","unstructured":"Tual-Chalot S, Garcia-Collado M, Redgrave RE, Singh E, Davison B, Park C, Lin H, Luli S, Jin Y, Wang Y, Lawrie A, Jakobsson L, Arthur HM (2020) Loss of endothelial endoglin promotes high-output heart failure through peripheral arteriovenous shunting driven by VEGF signaling. Circ Res 126(2):243\u2013257. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315974","journal-title":"Circ Res"},{"issue":"2","key":"9953_CR70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/dvg.20367","volume":"46","author":"S Claxton","year":"2008","unstructured":"Claxton S, Kostourou V, Jadeja S, Chambon P, Hodivala-Dilke K, Fruttiger M (2008) Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46(2):74\u201380. https:\/\/doi.org\/10.1002\/dvg.20367","journal-title":"Genesis"},{"issue":"4","key":"9953_CR71","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10456-020-09731-z","volume":"23","author":"E Singh","year":"2020","unstructured":"Singh E, Redgrave RE, Phillips HM, Arthur HM (2020) Arterial endoglin does not protect against arteriovenous malformations. Angiogenesis 23(4):559\u2013566. https:\/\/doi.org\/10.1007\/s10456-020-09731-z","journal-title":"Angiogenesis"},{"issue":"2","key":"9953_CR72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00018-011-0751-1","volume":"69","author":"M Bidart","year":"2012","unstructured":"Bidart M, Ricard N, Levet S, Samson M, Mallet C, David L, Subileau M, Tillet E, Feige JJ, Bailly S (2012) BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain. Cell Mol Life Sci 69(2):313\u2013324. https:\/\/doi.org\/10.1007\/s00018-011-0751-1","journal-title":"Cell Mol Life Sci"},{"issue":"26","key":"9953_CR73","doi-asserted-by":"publisher","first-page":"25111","DOI":"10.1074\/jbc.M503328200","volume":"280","author":"MA Brown","year":"2005","unstructured":"Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, Singh M, Tsareva T, Parice Y, Mahoney A, Roschke V, Sanyal I, Choe S (2005) Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280(26):25111\u201325118. https:\/\/doi.org\/10.1074\/jbc.M503328200","journal-title":"J Biol Chem"},{"issue":"34","key":"9953_CR74","doi-asserted-by":"publisher","first-page":"30034","DOI":"10.1074\/jbc.M111.260133","volume":"286","author":"R Castonguay","year":"2011","unstructured":"Castonguay R, Werner ED, Matthews RG, Presman E, Mulivor AW, Solban N, Sako D, Pearsall RS, Underwood KW, Seehra J, Kumar R, Grinberg AV (2011) Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem 286(34):30034\u201330046. https:\/\/doi.org\/10.1074\/jbc.M111.260133","journal-title":"J Biol Chem"},{"issue":"9","key":"9953_CR75","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1242\/dev.01094","volume":"131","author":"H Chen","year":"2004","unstructured":"Chen H, Shi S, Acosta L, Li W, Lu J, Bao S, Chen Z, Yang Z, Schneider MD, Chien KR, Conway SJ, Yoder MC, Haneline LS, Franco D, Shou W (2004) BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 131(9):2219\u20132231. https:\/\/doi.org\/10.1242\/dev.01094","journal-title":"Development"},{"issue":"5","key":"9953_CR76","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","volume":"109","author":"L David","year":"2007","unstructured":"David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109(5):1953\u20131961. https:\/\/doi.org\/10.1182\/blood-2006-07-034124","journal-title":"Blood"},{"issue":"2","key":"9953_CR77","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1158\/1535-7163.MCT-09-0650","volume":"9","author":"D Mitchell","year":"2010","unstructured":"Mitchell D, Pobre EG, Mulivor AW, Grinberg AV, Castonguay R, Monnell TE, Solban N, Ucran JA, Pearsall RS, Underwood KW, Seehra J, Kumar R (2010) ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth. Mol Cancer Ther 9(2):379\u2013388. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0650","journal-title":"Mol Cancer Ther"},{"issue":"Pt 6","key":"9953_CR78","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1242\/jcs.002949","volume":"120","author":"M Scharpfenecker","year":"2007","unstructured":"Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, ten Dijke P (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120(Pt 6):964\u2013972. https:\/\/doi.org\/10.1242\/jcs.002949","journal-title":"J Cell Sci"},{"issue":"28","key":"9953_CR79","doi-asserted-by":"publisher","first-page":"10963","DOI":"10.1074\/jbc.RA118.002968","volume":"293","author":"E Tillet","year":"2018","unstructured":"Tillet E, Ouarne M, Desroches-Castan A, Mallet C, Subileau M, Didier R, Lioutsko A, Belthier G, Feige JJ, Bailly S (2018) A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma. J Biol Chem 293(28):10963\u201310974. https:\/\/doi.org\/10.1074\/jbc.RA118.002968","journal-title":"J Biol Chem"},{"issue":"33","key":"9953_CR80","doi-asserted-by":"publisher","first-page":"27313","DOI":"10.1074\/jbc.M112.377960","volume":"287","author":"SA Townson","year":"2012","unstructured":"Townson SA, Martinez-Hackert E, Greppi C, Lowden P, Sako D, Liu J, Ucran JA, Liharska K, Underwood KW, Seehra J, Kumar R, Grinberg AV (2012) Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex. J Biol Chem 287(33):27313\u201327325. https:\/\/doi.org\/10.1074\/jbc.M112.377960","journal-title":"J Biol Chem"},{"issue":"29","key":"9953_CR81","doi-asserted-by":"publisher","first-page":"11887","DOI":"10.1073\/pnas.1306074110","volume":"110","author":"H Chen","year":"2013","unstructured":"Chen H, Brady Ridgway J, Sai T, Lai J, Warming S, Chen H, Roose-Girma M, Zhang G, Shou W, Yan M (2013) Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc Natl Acad Sci U S A 110(29):11887\u201311892. https:\/\/doi.org\/10.1073\/pnas.1306074110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9953_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10456-022-09859-0","volume":"26","author":"H Choi","year":"2023","unstructured":"Choi H, Kim BG, Kim YH, Lee SJ, Lee YJ, Oh SP (2023) BMP10 functions independently from BMP9 for the development of a proper arteriovenous network. Angiogenesis 26(1):167\u2013186. https:\/\/doi.org\/10.1007\/s10456-022-09859-0","journal-title":"Angiogenesis"},{"issue":"25","key":"9953_CR83","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1182\/blood-2012-01-407593","volume":"119","author":"N Ricard","year":"2012","unstructured":"Ricard N, Ciais D, Levet S, Subileau M, Mallet C, Zimmers TA, Lee SJ, Bidart M, Feige JJ, Bailly S (2012) BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 119(25):6162\u20136171. https:\/\/doi.org\/10.1182\/blood-2012-01-407593","journal-title":"Blood"},{"issue":"7","key":"9953_CR84","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1083\/jcb.201603106","volume":"214","author":"N Baeyens","year":"2016","unstructured":"Baeyens N, Larrivee B, Ola R, Hayward-Piatkowskyi B, Dubrac A, Huang B, Ross TD, Coon BG, Min E, Tsarfati M, Tong H, Eichmann A, Schwartz MA (2016) Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia. J Cell Biol 214(7):807\u2013816. https:\/\/doi.org\/10.1083\/jcb.201603106","journal-title":"J Cell Biol"},{"key":"9953_CR85","doi-asserted-by":"publisher","first-page":"13650","DOI":"10.1038\/ncomms13650","volume":"7","author":"R Ola","year":"2016","unstructured":"Ola R, Dubrac A, Han J, Zhang F, Fang JS, Larrivee B, Lee M, Urarte AA, Kraehling JR, Genet G, Hirschi KK, Sessa WC, Canals FV, Graupera M, Yan M, Young LH, Oh PS, Eichmann A (2016) PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nat Commun 7:13650. https:\/\/doi.org\/10.1038\/ncomms13650","journal-title":"Nat Commun"},{"key":"9953_CR86","doi-asserted-by":"publisher","first-page":"37366","DOI":"10.1038\/srep37366","volume":"5","author":"S Ruiz","year":"2016","unstructured":"Ruiz S, Zhao H, Chandakkar P, Chatterjee PK, Papoin J, Blanc L, Metz CN, Campagne F, Marambaud P (2016) A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10. Sci Rep 5:37366. https:\/\/doi.org\/10.1038\/srep37366","journal-title":"Sci Rep"},{"issue":"2","key":"9953_CR87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s0925-4773(98)00221-4","volume":"80","author":"H Neuhaus","year":"1999","unstructured":"Neuhaus H, Rosen V, Thies RS (1999) Heart specific expression of mouse BMP-10 a novel member of the TGF-beta superfamily. Mech Dev 80(2):181\u2013184. https:\/\/doi.org\/10.1016\/s0925-4773(98)00221-4","journal-title":"Mech Dev"},{"issue":"2","key":"9953_CR88","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10456-019-09701-0","volume":"23","author":"TL Capasso","year":"2020","unstructured":"Capasso TL, Li B, Volek HJ, Khalid W, Rochon ER, Anbalagan A, Herdman C, Yost HJ, Villanueva FS, Kim K, Roman BL (2020) BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance. Angiogenesis 23(2):203\u2013220. https:\/\/doi.org\/10.1007\/s10456-019-09701-0","journal-title":"Angiogenesis"},{"issue":"7","key":"9953_CR89","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/cvr\/cvab187","volume":"118","author":"C Bouvard","year":"2022","unstructured":"Bouvard C, Tu L, Rossi M, Desroches-Castan A, Berrebeh N, Helfer E, Roelants C, Liu H, Ouarne M, Chaumontel N, Mallet C, Battail C, Bikfalvi A, Humbert M, Savale L, Daubon T, Perret P, Tillet E, Guignabert C, Bailly S (2022) Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10. Cardiovasc Res 118(7):1805\u20131820. https:\/\/doi.org\/10.1093\/cvr\/cvab187","journal-title":"Cardiovasc Res"},{"issue":"21","key":"9953_CR90","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1128\/MCB.00577-07","volume":"27","author":"Y Lan","year":"2007","unstructured":"Lan Y, Liu B, Yao H, Li F, Weng T, Yang G, Li W, Cheng X, Mao N, Yang X (2007) Essential role of endothelial Smad4 in vascular remodeling and integrity. Mol Cell Biol 27(21):7683\u20137692. https:\/\/doi.org\/10.1128\/MCB.00577-07","journal-title":"Mol Cell Biol"},{"issue":"3","key":"9953_CR91","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.devcel.2011.01.011","volume":"20","author":"F Li","year":"2011","unstructured":"Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, Han H, Meng A, Wang Y, Yang X (2011) Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with notch. Dev Cell 20(3):291\u2013302. https:\/\/doi.org\/10.1016\/j.devcel.2011.01.011","journal-title":"Dev Cell"},{"issue":"21","key":"9953_CR92","doi-asserted-by":"publisher","first-page":"e009514","DOI":"10.1161\/JAHA.118.009514","volume":"7","author":"YH Kim","year":"2018","unstructured":"Kim YH, Choe SW, Chae MY, Hong S, Oh SP (2018) SMAD4 deficiency leads to development of arteriovenous malformations in neonatal and adult mice. J Am Heart Assoc 7(21):e009514. https:\/\/doi.org\/10.1161\/JAHA.118.009514","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"9953_CR93","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10456-018-9602-0","volume":"21","author":"AM Crist","year":"2018","unstructured":"Crist AM, Lee AR, Patel NR, Westhoff DE, Meadows SM (2018) Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of hereditary hemorrhagic telangiectasia. Angiogenesis 21(2):363\u2013380. https:\/\/doi.org\/10.1007\/s10456-018-9602-0","journal-title":"Angiogenesis"},{"issue":"21","key":"9953_CR94","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1161\/CIRCULATIONAHA.118.033842","volume":"138","author":"R Ola","year":"2018","unstructured":"Ola R, Kunzel SH, Zhang F, Genet G, Chakraborty R, Pibouin-Fragner L, Martin K, Sessa W, Dubrac A, Eichmann A (2018) SMAD4 prevents flow induced arteriovenous malformations by inhibiting casein kinase 2. Circulation 138(21):2379\u20132394. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033842","journal-title":"Circulation"},{"issue":"17","key":"9953_CR95","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1161\/CIRCULATIONAHA.118.036952","volume":"139","author":"AM Crist","year":"2019","unstructured":"Crist AM, Zhou X, Garai J, Lee AR, Thoele J, Ullmer C, Klein C, Zabaleta J, Meadows SM (2019) Angiopoietin-2 inhibition rescues arteriovenous malformation in a Smad4 hereditary hemorrhagic telangiectasia mouse model. Circulation 139(17):2049\u20132063. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036952","journal-title":"Circulation"},{"key":"9953_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030488","author":"A Benn","year":"2020","unstructured":"Benn A, Alonso F, Mangelschots J, Genot E, Lox M, Zwijsen A (2020) BMP-SMAD1\/5 signaling regulates retinal vascular development. Biomolecules. https:\/\/doi.org\/10.3390\/biom10030488","journal-title":"Biomolecules"},{"issue":"3\u20134","key":"9953_CR97","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00508-006-0561-x","volume":"118","author":"H Sadick","year":"2006","unstructured":"Sadick H, Sadick M, Gotte K, Naim R, Riedel F, Bran G, Hormann K (2006) Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures. Wien Klin Wochenschr 118(3\u20134):72\u201380. https:\/\/doi.org\/10.1007\/s00508-006-0561-x","journal-title":"Wien Klin Wochenschr"},{"issue":"4","key":"9953_CR98","doi-asserted-by":"publisher","first-page":"H959","DOI":"10.1152\/ajpheart.01251.2009","volume":"299","author":"JM Lopez-Novoa","year":"2010","unstructured":"Lopez-Novoa JM, Bernabeu C (2010) The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol 299(4):H959-974. https:\/\/doi.org\/10.1152\/ajpheart.01251.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"9953_CR99","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/14728222.2017.1365839","volume":"21","author":"L Ruiz-Llorente","year":"2017","unstructured":"Ruiz-Llorente L, Gallardo-Vara E, Rossi E, Smadja DM, Botella LM, Bernabeu C (2017) Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert Opin Ther Targets 21(10):933\u2013947. https:\/\/doi.org\/10.1080\/14728222.2017.1365839","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"9953_CR100","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","volume":"105","author":"DA Snellings","year":"2019","unstructured":"Snellings DA, Gallione CJ, Clark DS, Vozoris NT, Faughnan ME, Marchuk DA (2019) Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in Bi-allelic loss of ENG or ACVRL1. Am J Hum Genet 105(5):894\u2013906. https:\/\/doi.org\/10.1016\/j.ajhg.2019.09.010","journal-title":"Am J Hum Genet"},{"issue":"14","key":"9953_CR101","doi-asserted-by":"publisher","first-page":"7682","DOI":"10.3390\/ijms25147682","volume":"25","author":"KJ Whitehead","year":"2024","unstructured":"Whitehead KJ, Toydemir D, Wooderchak-Donahue W, Oakley GM, McRae B, Putnam A, McDonald J, Bayrak-Toydemir P (2024) Investigation of the genetic determinants of telangiectasia and solid organ arteriovenous malformation formation in hereditary hemorrhagic telangiectasia (HHT). Int J Mol Sci 25(14):7682. https:\/\/doi.org\/10.3390\/ijms25147682","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9953_CR102","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/ATVBAHA.112.300485","volume":"33","author":"W Chen","year":"2013","unstructured":"Chen W, Guo Y, Walker EJ, Shen F, Jun K, Oh SP, Degos V, Lawton MT, Tihan T, Davalos D, Akassoglou K, Nelson J, Pile-Spellman J, Su H, Young WL (2013) Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain. Arterioscler Thromb Vasc Biol 33(2):305\u2013310. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300485","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"9953_CR103","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10456-014-9436-3","volume":"17","author":"C Han","year":"2014","unstructured":"Han C, Choe SW, Kim YH, Acharya AP, Keselowsky BG, Sorg BS, Lee YJ, Oh SP (2014) VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2. Angiogenesis 17(4):823\u2013830. https:\/\/doi.org\/10.1007\/s10456-014-9436-3","journal-title":"Angiogenesis"},{"issue":"8","key":"9953_CR104","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.109.211037","volume":"106","author":"M Mahmoud","year":"2010","unstructured":"Mahmoud M, Allinson KR, Zhai Z, Oakenfull R, Ghandi P, Adams RH, Fruttiger M, Arthur HM (2010) Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 106(8):1425\u20131433. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.211037","journal-title":"Circ Res"},{"key":"9953_CR105","doi-asserted-by":"publisher","unstructured":"Han C, Nguyen CL, Scherschinski L, Schriber TD, Arthur HM, Lawton MT, Oh SP (2023) VEGFR2 Expression correlates with postnatal development of brain arteriovenous malformations in a mouse model of type I hereditary hemorrhagic telangiectasia. Biomedicines PMC10740421. https:\/\/doi.org\/10.3390\/biomedicines11123153","DOI":"10.3390\/biomedicines11123153"},{"issue":"2","key":"9953_CR106","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1227\/01.neu.0000103421.35266.71","volume":"54","author":"T Hashimoto","year":"2004","unstructured":"Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly T Jr, Stewart CL, Dressman HK, Barbaro NM, Marchuk DA, Young WL (2004) Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54(2):410\u2013423. https:\/\/doi.org\/10.1227\/01.neu.0000103421.35266.71","journal-title":"Neurosurgery"},{"issue":"20","key":"9953_CR107","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/ajmg.a.31450","volume":"140","author":"P Bayrak-Toydemir","year":"2006","unstructured":"Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R (2006) A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 140(20):2155\u20132162. https:\/\/doi.org\/10.1002\/ajmg.a.31450","journal-title":"Am J Med Genet A"},{"issue":"7","key":"9953_CR108","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jmg.2004.028712","volume":"42","author":"SG Cole","year":"2005","unstructured":"Cole SG, Begbie ME, Wallace GM, Shovlin CL (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42(7):577\u2013582. https:\/\/doi.org\/10.1136\/jmg.2004.028712","journal-title":"J Med Genet"},{"key":"9953_CR109","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan6831","author":"X Jiang","year":"2018","unstructured":"Jiang X, Wooderchak-Donahue WL, McDonald J, Ghatpande P, Baalbaki M, Sandoval M, Hart D, Clay H, Coughlin S, Lagna G, Bayrak-Toydemir P, Hata A (2018) Inactivating mutations in Drosha mediate vascular abnormalities similar to hereditary hemorrhagic telangiectasia. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aan6831","journal-title":"Sci Signal"},{"issue":"6956","key":"9953_CR110","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature01957","volume":"425","author":"Y Lee","year":"2003","unstructured":"Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415\u2013419. https:\/\/doi.org\/10.1038\/nature01957","journal-title":"Nature"},{"issue":"7200","key":"9953_CR111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature07086","volume":"454","author":"BN Davis","year":"2008","unstructured":"Davis BN, Hilyard AC, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454(7200):56\u201361. https:\/\/doi.org\/10.1038\/nature07086","journal-title":"Nature"},{"issue":"2","key":"9953_CR112","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MX (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137(2):216\u2013233. https:\/\/doi.org\/10.1016\/j.cell.2009.03.045","journal-title":"Cell"},{"issue":"5","key":"9953_CR113","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3171\/2016.3.JNS151731","volume":"126","author":"D Delev","year":"2017","unstructured":"Delev D, Pavlova A, Grote A, Bostrom A, Hollig A, Schramm J, Fimmers R, Oldenburg J, Simon M (2017) NOTCH4 gene polymorphisms as potential risk factors for brain arteriovenous malformation development and hemorrhagic presentation. J Neurosurg 126(5):1552\u20131559. https:\/\/doi.org\/10.3171\/2016.3.JNS151731","journal-title":"J Neurosurg"},{"issue":"Pt 12","key":"9953_CR114","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1093\/brain\/awp246","volume":"132","author":"Q ZhuGe","year":"2009","unstructured":"ZhuGe Q, Zhong M, Zheng W, Yang GY, Mao X, Xie L, Chen G, Chen Y, Lawton MT, Young WL, Greenberg DA, Jin K (2009) Notch-1 signalling is activated in brain arteriovenous malformations in humans. Brain 132(Pt 12):3231\u20133241. https:\/\/doi.org\/10.1093\/brain\/awp246","journal-title":"Brain"},{"issue":"8","key":"9953_CR115","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1111\/jcmm.12580","volume":"19","author":"S Hill-Felberg","year":"2015","unstructured":"Hill-Felberg S, Wu HH, Toms SA, Dehdashti AR (2015) Notch receptor expression in human brain arteriovenous malformations. J Cell Mol Med 19(8):1986\u20131993. https:\/\/doi.org\/10.1111\/jcmm.12580","journal-title":"J Cell Mol Med"},{"issue":"20","key":"9953_CR116","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1101\/gad.1239004","volume":"18","author":"A Duarte","year":"2004","unstructured":"Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J (2004) Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 18(20):2474\u20132478. https:\/\/doi.org\/10.1101\/gad.1239004","journal-title":"Genes Dev"},{"issue":"45","key":"9953_CR117","doi-asserted-by":"publisher","first-page":"15949","DOI":"10.1073\/pnas.0407290101","volume":"101","author":"NW Gale","year":"2004","unstructured":"Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, Thurston G, Yancopoulos GD (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 101(45):15949\u201315954. https:\/\/doi.org\/10.1073\/pnas.0407290101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"9953_CR118","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1101\/gad.1239204","volume":"18","author":"LT Krebs","year":"2004","unstructured":"Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T (2004) Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 18(20):2469\u20132473. https:\/\/doi.org\/10.1101\/gad.1239204","journal-title":"Genes Dev"},{"issue":"11","key":"9953_CR119","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.14.11.1343","volume":"14","author":"LT Krebs","year":"2000","unstructured":"Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14(11):1343\u20131352","journal-title":"Genes Dev"},{"issue":"19","key":"9953_CR120","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1242\/dev.128.19.3675","volume":"128","author":"ND Lawson","year":"2001","unstructured":"Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128(19):3675\u20133683. https:\/\/doi.org\/10.1242\/dev.128.19.3675","journal-title":"Development"},{"issue":"7","key":"9953_CR121","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1242\/dev.099986","volume":"141","author":"A Quillien","year":"2014","unstructured":"Quillien A, Moore JC, Shin M, Siekmann AF, Smith T, Pan L, Moens CB, Parsons MJ, Lawson ND (2014) Distinct Notch signaling outputs pattern the developing arterial system. Development 141(7):1544\u20131552. https:\/\/doi.org\/10.1242\/dev.099986","journal-title":"Development"},{"issue":"6","key":"9953_CR122","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1101\/gad.8.6.707","volume":"8","author":"PJ Swiatek","year":"1994","unstructured":"Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T (1994) Notch1 is essential for postimplantation development in mice. Genes Dev 8(6):707\u2013719. https:\/\/doi.org\/10.1101\/gad.8.6.707","journal-title":"Genes Dev"},{"issue":"3","key":"9953_CR123","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/dvdy.24252","volume":"244","author":"JE Fish","year":"2015","unstructured":"Fish JE, Wythe JD (2015) The molecular regulation of arteriovenous specification and maintenance. Dev Dyn 244(3):391\u2013409. https:\/\/doi.org\/10.1002\/dvdy.24252","journal-title":"Dev Dyn"},{"issue":"28","key":"9953_CR124","doi-asserted-by":"publisher","first-page":"9884","DOI":"10.1073\/pnas.0504391102","volume":"102","author":"TR Carlson","year":"2005","unstructured":"Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ, Messina LM, Capobianco AJ, Werb Z, Wang R (2005) Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci USA 102(28):9884\u20139889. https:\/\/doi.org\/10.1073\/pnas.0504391102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"117","key":"9953_CR125","doi-asserted-by":"publisher","first-page":"117ra118","DOI":"10.1126\/scitranslmed.3002670","volume":"4","author":"PA Murphy","year":"2012","unstructured":"Murphy PA, Kim TN, Lu G, Bollen AW, Schaffer CB, Wang RA (2012) Notch4 normalization reduces blood vessel size in arteriovenous malformations. Sci Transl Med 4(117):117ra118. https:\/\/doi.org\/10.1126\/scitranslmed.3002670","journal-title":"Sci Transl Med"},{"issue":"31","key":"9953_CR126","doi-asserted-by":"publisher","first-page":"10901","DOI":"10.1073\/pnas.0802743105","volume":"105","author":"PA Murphy","year":"2008","unstructured":"Murphy PA, Lam MT, Wu X, Kim TN, Vartanian SM, Bollen AW, Carlson TR, Wang RA (2008) Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc Natl Acad Sci USA 105(31):10901\u201310906. https:\/\/doi.org\/10.1073\/pnas.0802743105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"50","key":"9953_CR127","doi-asserted-by":"publisher","first-page":"18007","DOI":"10.1073\/pnas.1415316111","volume":"111","author":"PA Murphy","year":"2014","unstructured":"Murphy PA, Kim TN, Huang L, Nielsen CM, Lawton MT, Adams RH, Schaffer CB, Wang RA (2014) Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels. Proc Natl Acad Sci USA 111(50):18007\u201318012. https:\/\/doi.org\/10.1073\/pnas.1415316111","journal-title":"Proc Natl Acad Sci USA"},{"key":"9953_CR128","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211390","author":"CM Nielsen","year":"2023","unstructured":"Nielsen CM, Zhang X, Raygor K, Wang S, Bollen AW, Wang RA (2023) Endothelial Rbpj deletion normalizes Notch4-induced brain arteriovenous malformation in mice. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20211390","journal-title":"J Exp Med"},{"key":"9953_CR129","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-022-01429-w","author":"AD Chapman","year":"2022","unstructured":"Chapman AD, Selhorst S, LaComb J, LeDantec-Boswell A, Wohl TR, Adhicary S, Nielsen CM (2022) Endothelial Rbpj is required for cerebellar morphogenesis and motor control in the early postnatal mouse brain. Cerebellum. https:\/\/doi.org\/10.1007\/s12311-022-01429-w","journal-title":"Cerebellum"},{"issue":"19","key":"9953_CR130","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1242\/dev.108951","volume":"141","author":"CM Nielsen","year":"2014","unstructured":"Nielsen CM, Cuervo H, Ding VW, Kong Y, Huang EJ, Wang RA (2014) Deletion of Rbpj from postnatal endothelium leads to abnormal arteriovenous shunting in mice. Development 141(19):3782\u20133792. https:\/\/doi.org\/10.1242\/dev.108951","journal-title":"Development"},{"issue":"14","key":"9953_CR131","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1242\/dev.093351","volume":"140","author":"M Ehling","year":"2013","unstructured":"Ehling M, Adams S, Benedito R, Adams RH (2013) Notch controls retinal blood vessel maturation and quiescence. Development 140(14):3051\u20133061. https:\/\/doi.org\/10.1242\/dev.093351","journal-title":"Development"},{"issue":"6","key":"9953_CR132","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3171\/2017.6.JNS17860","volume":"129","author":"EA Winkler","year":"2018","unstructured":"Winkler EA, Birk H, Burkhardt JK, Chen X, Yue JK, Guo D, Rutledge WC, Lasker GF, Partow C, Tihan T, Chang EF, Su H, Kim H, Walcott BP, Lawton MT (2018) Reductions in brain pericytes are associated with arteriovenous malformation vascular instability. J Neurosurg 129(6):1464\u20131474. https:\/\/doi.org\/10.3171\/2017.6.JNS17860","journal-title":"J Neurosurg"},{"issue":"3","key":"9953_CR133","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.devcel.2012.02.005","volume":"22","author":"B Larrivee","year":"2012","unstructured":"Larrivee B, Prahst C, Gordon E, del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A (2012) ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell 22(3):489\u2013500. https:\/\/doi.org\/10.1016\/j.devcel.2012.02.005","journal-title":"Dev Cell"},{"issue":"47","key":"9953_CR134","doi-asserted-by":"publisher","first-page":"19071","DOI":"10.1073\/pnas.1310905110","volume":"110","author":"Y Yao","year":"2013","unstructured":"Yao Y, Yao J, Radparvar M, Blazquez-Medela AM, Guihard PJ, Jumabay M, Bostrom KI (2013) Reducing Jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix Gla protein deficiency. Proc Natl Acad Sci USA 110(47):19071\u201319076. https:\/\/doi.org\/10.1073\/pnas.1310905110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9953_CR135","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1056\/NEJMoa1709449","volume":"378","author":"SI Nikolaev","year":"2018","unstructured":"Nikolaev SI, Vetiska S, Bonilla X, Boudreau E, Jauhiainen S, Rezai Jahromi B, Khyzha N, DiStefano PV, Suutarinen S, Kiehl TR, Mendes Pereira V, Herman AM, Krings T, Andrade-Barazarte H, Tung T, Valiante T, Zadeh G, Tymianski M, Rauramaa T, Yla-Herttuala S, Wythe JD, Antonarakis SE, Frosen J, Fish JE, Radovanovic I (2018) Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 378(3):250\u2013261. https:\/\/doi.org\/10.1056\/NEJMoa1709449","journal-title":"N Engl J Med"},{"issue":"3","key":"9953_CR136","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccr.2014.02.017","volume":"25","author":"AG Stephen","year":"2014","unstructured":"Stephen AG, Esposito D, Bagni RK, McCormick F (2014) Dragging ras back in the ring. Cancer Cell 25(3):272\u2013281. https:\/\/doi.org\/10.1016\/j.ccr.2014.02.017","journal-title":"Cancer Cell"},{"issue":"7","key":"9953_CR137","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm2438","volume":"9","author":"AE Karnoub","year":"2008","unstructured":"Karnoub AE, Weinberg RA (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9(7):517\u2013531. https:\/\/doi.org\/10.1038\/nrm2438","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"9953_CR138","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/1591019920982810","volume":"27","author":"O Bameri","year":"2021","unstructured":"Bameri O, Salarzaei M, Parooie F (2021) KRAS\/BRAF mutations in brain arteriovenous malformations: a systematic review and meta-analysis. Interv Neuroradiol 27(4):539\u2013546. https:\/\/doi.org\/10.1177\/1591019920982810","journal-title":"Interv Neuroradiol"},{"issue":"12","key":"9953_CR139","doi-asserted-by":"publisher","first-page":"e0226852","DOI":"10.1371\/journal.pone.0226852","volume":"14","author":"JA Goss","year":"2019","unstructured":"Goss JA, Huang AY, Smith E, Konczyk DJ, Smits PJ, Sudduth CL, Stapleton C, Patel A, Alexandrescu S, Warman ML, Greene AK (2019) Somatic mutations in intracranial arteriovenous malformations. PLoS ONE 14(12):e0226852. https:\/\/doi.org\/10.1371\/journal.pone.0226852","journal-title":"PLoS ONE"},{"issue":"1","key":"9953_CR140","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/brain\/awy307","volume":"142","author":"T Hong","year":"2019","unstructured":"Hong T, Yan Y, Li J, Radovanovic I, Ma X, Shao YW, Yu J, Ma Y, Zhang P, Ling F, Huang S, Zhang H, Wang Y (2019) High prevalence of KRAS\/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain 142(1):23\u201334. https:\/\/doi.org\/10.1093\/brain\/awy307","journal-title":"Brain"},{"issue":"1","key":"9953_CR141","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/2020.11.JNS202031","volume":"136","author":"S Gao","year":"2022","unstructured":"Gao S, Nelson J, Weinsheimer S, Winkler EA, Rutledge C, Abla AA, Gupta N, Shieh JT, Cooke DL, Hetts SW, Tihan T, Hess CP, Ko N, Walcott BP, McCulloch CE, Lawton MT, Su H, Pawlikowska L, Kim H (2022) Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype. J Neurosurg 136(1):148\u2013155. https:\/\/doi.org\/10.3171\/2020.11.JNS202031","journal-title":"J Neurosurg"},{"key":"9953_CR142","doi-asserted-by":"publisher","first-page":"e1365","DOI":"10.1016\/j.wneu.2019.03.105","volume":"126","author":"M Oka","year":"2019","unstructured":"Oka M, Kushamae M, Aoki T, Yamaguchi T, Kitazato K, Abekura Y, Kawamata T, Mizutani T, Miyamoto S, Takagi Y (2019) KRAS G12D or G12V mutation in human brain arteriovenous malformations. World Neurosurg 126:e1365\u2013e1373. https:\/\/doi.org\/10.1016\/j.wneu.2019.03.105","journal-title":"World Neurosurg"},{"key":"9953_CR143","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.humpath.2019.04.004","volume":"89","author":"DS Priemer","year":"2019","unstructured":"Priemer DS, Vortmeyer AO, Zhang S, Chang HY, Curless KL, Cheng L (2019) Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation. Hum Pathol 89:33\u201339. https:\/\/doi.org\/10.1016\/j.humpath.2019.04.004","journal-title":"Hum Pathol"},{"issue":"6","key":"9953_CR144","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/2159-8290.CD-19-0406","volume":"9","author":"GA Hobbs","year":"2019","unstructured":"Hobbs GA, Der CJ (2019) RAS mutations are not created equal. Cancer Discov 9(6):696\u2013698. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0406","journal-title":"Cancer Discov"},{"issue":"1","key":"9953_CR145","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","volume":"170","author":"DK Simanshu","year":"2017","unstructured":"Simanshu DK, Nissley DV, McCormick F (2017) RAS proteins and their regulators in human disease. Cell 170(1):17\u201333. https:\/\/doi.org\/10.1016\/j.cell.2017.06.009","journal-title":"Cell"},{"issue":"6","key":"9953_CR146","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1161\/CIRCRESAHA.119.316500","volume":"127","author":"JE Fish","year":"2020","unstructured":"Fish JE, Flores Suarez CP, Boudreau E, Herman AM, Gutierrez MC, Gustafson D, DiStefano PV, Cui M, Chen Z, De Ruiz KB, Schexnayder TS, Ward CS, Radovanovic I, Wythe JD (2020) Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that require MEK but Not PI3K signaling. Circ Res 127(6):727\u2013743. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316500","journal-title":"Circ Res"},{"issue":"5","key":"9953_CR147","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.cell.2007.03.051","volume":"129","author":"S Gupta","year":"2007","unstructured":"Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J (2007) Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 129(5):957\u2013968. https:\/\/doi.org\/10.1016\/j.cell.2007.03.051","journal-title":"Cell"},{"issue":"8","key":"9953_CR148","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1172\/JCI74134","volume":"124","author":"MM Murillo","year":"2014","unstructured":"Murillo MM, Zelenay S, Nye E, Castellano E, Lassailly F, Stamp G, Downward J (2014) RAS interaction with PI3K p110alpha is required for tumor-induced angiogenesis. J Clin Invest 124(8):3601\u20133611. https:\/\/doi.org\/10.1172\/JCI74134","journal-title":"J Clin Invest"},{"issue":"21","key":"9953_CR149","doi-asserted-by":"publisher","first-page":"9719","DOI":"10.1158\/0008-5472.CAN-05-1683","volume":"65","author":"V Emuss","year":"2005","unstructured":"Emuss V, Garnett M, Mason C, Marais R (2005) Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF. Cancer Res 65(21):9719\u20139726. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1683","journal-title":"Cancer Res"},{"issue":"7","key":"9953_CR150","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1074\/jbc.272.7.4378","volume":"272","author":"R Marais","year":"1997","unstructured":"Marais R, Light Y, Paterson HF, Mason CS, Marshall CJ (1997) Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J Biol Chem 272(7):4378\u20134383. https:\/\/doi.org\/10.1074\/jbc.272.7.4378","journal-title":"J Biol Chem"},{"issue":"8","key":"9953_CR151","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1093\/emboj\/18.8.2137","volume":"18","author":"CS Mason","year":"1999","unstructured":"Mason CS, Springer CJ, Cooper RG, Superti-Furga G, Marshall CJ, Marais R (1999) Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J 18(8):2137\u20132148. https:\/\/doi.org\/10.1093\/emboj\/18.8.2137","journal-title":"EMBO J"},{"issue":"11","key":"9953_CR152","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1128\/MCB.15.11.6430","volume":"15","author":"CA Pritchard","year":"1995","unstructured":"Pritchard CA, Samuels ML, Bosch E, McMahon M (1995) Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol 15(11):6430\u20136442. https:\/\/doi.org\/10.1128\/MCB.15.11.6430","journal-title":"Mol Cell Biol"},{"issue":"6","key":"9953_CR153","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.molcel.2019.09.004","volume":"76","author":"EM Terrell","year":"2019","unstructured":"Terrell EM, Durrant DE, Ritt DA, Sealover NE, Sheffels E, Spencer-Smith R, Esposito D, Zhou Y, Hancock JF, Kortum RL, Morrison DK (2019) Distinct binding preferences between Ras and Raf family members and the impact on oncogenic Ras signaling. Mol Cell 76(6):872\u2013884. https:\/\/doi.org\/10.1016\/j.molcel.2019.09.004","journal-title":"Mol Cell"},{"issue":"2","key":"9953_CR154","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/sj.onc.1203261","volume":"19","author":"CK Weber","year":"2000","unstructured":"Weber CK, Slupsky JR, Herrmann C, Schuler M, Rapp UR, Block C (2000) Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes. Oncogene 19(2):169\u2013176. https:\/\/doi.org\/10.1038\/sj.onc.1203261","journal-title":"Oncogene"},{"issue":"3","key":"9953_CR155","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","volume":"100","author":"JA Couto","year":"2017","unstructured":"Couto JA, Huang AY, Konczyk DJ, Goss JA, Fishman SJ, Mulliken JB, Warman ML, Greene AK (2017) Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet 100(3):546\u2013554. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.018","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9953_CR156","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1038\/s41598-023-35301-6","volume":"13","author":"CL Sudduth","year":"2023","unstructured":"Sudduth CL, Smits PJ, Vivero MP, Cheng YS, Ad M, Konczyk DJ, Bischoff J, Warman ML, Greene AK (2023) Arteriovenous malformation Map2k1 mutation affects vasculogenesis. Sci Rep 13(1):11074. https:\/\/doi.org\/10.1038\/s41598-023-35301-6","journal-title":"Sci Rep"},{"issue":"8","key":"9953_CR157","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1158\/1078-0432.CCR-14-2124","volume":"21","author":"ME Arcila","year":"2015","unstructured":"Arcila ME, Drilon A, Sylvester BE, Lovly CM, Borsu L, Reva B, Kris MG, Solit DB, Ladanyi M (2015) MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking. Clin Cancer Res 21(8):1935\u20131943. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2124","journal-title":"Clin Cancer Res"},{"issue":"19","key":"9953_CR158","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","volume":"124","author":"R Chakraborty","year":"2014","unstructured":"Chakraborty R, Hampton OA, Shen X, Simko SJ, Shih A, Abhyankar H, Lim KP, Covington KR, Trevino L, Dewal N, Muzny DM, Doddapaneni H, Hu J, Wang L, Lupo PJ, Hicks MJ, Bonilla DL, Dwyer KC, Berres ML, Poulikakos PI, Merad M, McClain KL, Wheeler DA, Allen CE, Parsons DW (2014) Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood 124(19):3007\u20133015. https:\/\/doi.org\/10.1182\/blood-2014-05-577825","journal-title":"Blood"},{"issue":"2","key":"9953_CR159","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.1026","volume":"44","author":"SI Nikolaev","year":"2011","unstructured":"Nikolaev SI, Rimoldi D, Iseli C, Valsesia A, Robyr D, Gehrig C, Harshman K, Guipponi M, Bukach O, Zoete V, Michielin O, Muehlethaler K, Speiser D, Beckmann JS, Xenarios I, Halazonetis TD, Jongeneel CV, Stevenson BJ, Antonarakis SE (2011) Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 44(2):133\u2013139. https:\/\/doi.org\/10.1038\/ng.1026","journal-title":"Nat Genet"},{"issue":"5765","key":"9953_CR160","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1126\/science.1124642","volume":"311","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA (2006) Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311(5765):1287\u20131290. https:\/\/doi.org\/10.1126\/science.1124642","journal-title":"Science"},{"issue":"24","key":"9953_CR161","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1101\/gad.943001","volume":"15","author":"EL Jackson","year":"2001","unstructured":"Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15(24):3243\u20133248. https:\/\/doi.org\/10.1101\/gad.943001","journal-title":"Genes Dev"},{"issue":"7297","key":"9953_CR162","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","volume":"465","author":"Y Wang","year":"2010","unstructured":"Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, Barberis A, Benjamin LE, Makinen T, Nobes CD, Adams RH (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483\u2013486. https:\/\/doi.org\/10.1038\/nature09002","journal-title":"Nature"},{"key":"9953_CR163","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.15.594335","author":"CF Suarez","year":"2024","unstructured":"Suarez CF, Harb OA, Robledo A, Largoza G, Ahn JJ, Alley EK, Wu T, Veeraragavan S, McClugage ST, Iacobas I, Fish JE, Kan PT, Marrelli SP, Wythe JD (2024) MEK signaling represents a viable therapeutic vulnerability of KRAS-driven somatic brain arteriovenous malformations. bioRxiv. https:\/\/doi.org\/10.1101\/2024.05.15.594335","journal-title":"bioRxiv"},{"issue":"10","key":"9953_CR164","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","volume":"72","author":"IA Prior","year":"2012","unstructured":"Prior IA, Lewis PD, Mattos C (2012) A comprehensive survey of Ras mutations in cancer. Cancer Res 72(10):2457\u20132467. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2612","journal-title":"Cancer Res"},{"issue":"13","key":"9953_CR165","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1084\/jem.20110398","volume":"208","author":"DA Ridder","year":"2011","unstructured":"Ridder DA, Lang MF, Salinin S, Roderer JP, Struss M, Maser-Gluth C, Schwaninger M (2011) TAK1 in brain endothelial cells mediates fever and lethargy. J Exp Med 208(13):2615\u20132623. https:\/\/doi.org\/10.1084\/jem.20110398","journal-title":"J Exp Med"},{"issue":"5","key":"9953_CR166","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/ana.26059","volume":"89","author":"ES Park","year":"2021","unstructured":"Park ES, Kim S, Huang S, Yoo JY, Korbelin J, Lee TJ, Kaur B, Dash PK, Chen PR, Kim E (2021) Selective endothelial hyperactivation of oncogenic KRAS induces brain arteriovenous malformations in mice. Ann Neurol 89(5):926\u2013941. https:\/\/doi.org\/10.1002\/ana.26059","journal-title":"Ann Neurol"},{"key":"9953_CR167","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309160","author":"A Fraissenon","year":"2024","unstructured":"Fraissenon A, Bayard C, Morin G, Benichi S, Hoguin C, Protic S, Zerbib L, Ladraa S, Firpion M, Blauwblomme T, Naggara O, Duruisseaux M, Delous M, Boitel C, Bringuier PP, Payen L, Legendre C, Kaltenbach S, Balducci E, Villarese P, Asnafi V, Bisdorff A, Guibaud L, Canaud G (2024) Sotorasib for vascular malformations associated with KRAS G12C mutation. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2309160","journal-title":"N Engl J Med"},{"issue":"11","key":"9953_CR168","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1016\/j.celrep.2018.08.025","volume":"24","author":"QF Li","year":"2018","unstructured":"Li QF, Decker-Rockefeller B, Bajaj A, Pumiglia K (2018) Activation of Ras in the vascular endothelium induces brain vascular malformations and hemorrhagic stroke. Cell Rep 24(11):2869\u20132882. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.025","journal-title":"Cell Rep"},{"issue":"6","key":"9953_CR169","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1086\/379793","volume":"73","author":"I Eerola","year":"2003","unstructured":"Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, Vanwijck R, Vikkula M (2003) Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73(6):1240\u20131249. https:\/\/doi.org\/10.1086\/379793","journal-title":"Am J Hum Genet"},{"issue":"7","key":"9953_CR170","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/humu.20746","volume":"29","author":"N Revencu","year":"2008","unstructured":"Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, Clapuyt P, Hammer F, Dubois J, Baselga E, Brancati F, Carder R, Quintal JM, Dallapiccola B, Fischer G, Frieden IJ, Garzon M, Harper J, Johnson-Patel J, Labreze C, Martorell L, Paltiel HJ, Pohl A, Prendiville J, Quere I, Siegel DH, Valente EM, Van Hagen A, Van Hest L, Vaux KK, Vicente A, Weibel L, Chitayat D, Vikkula M (2008) Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 29(7):959\u2013965. https:\/\/doi.org\/10.1002\/humu.20746","journal-title":"Hum Mutat"},{"issue":"9","key":"9953_CR171","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1172\/JCI124917","volume":"129","author":"D Chen","year":"2019","unstructured":"Chen D, Teng JM, North PE, Lapinski PE, King PD (2019) RASA1-dependent cellular export of collagen IV controls blood and lymphatic vascular development. J Clin Invest 129(9):3545\u20133561. https:\/\/doi.org\/10.1172\/JCI124917","journal-title":"J Clin Invest"},{"issue":"6551","key":"9953_CR172","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/377695a0","volume":"377","author":"M Henkemeyer","year":"1995","unstructured":"Henkemeyer M, Rossi DJ, Holmyard DP, Puri MC, Mbamalu G, Harpal K, Shih TS, Jacks T, Pawson T (1995) Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377(6551):695\u2013701. https:\/\/doi.org\/10.1038\/377695a0","journal-title":"Nature"},{"issue":"2","key":"9953_CR173","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1172\/JCI46116","volume":"122","author":"PE Lapinski","year":"2012","unstructured":"Lapinski PE, Kwon S, Lubeck BA, Wilkinson JE, Srinivasan RS, Sevick-Muraca E, King PD (2012) RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice. J Clin Invest 122(2):733\u2013747. https:\/\/doi.org\/10.1172\/JCI46116","journal-title":"J Clin Invest"},{"issue":"7","key":"9953_CR174","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1172\/JCI89607","volume":"127","author":"PE Lapinski","year":"2017","unstructured":"Lapinski PE, Lubeck BA, Chen D, Doosti A, Zawieja SD, Davis MJ, King PD (2017) RASA1 regulates the function of lymphatic vessel valves in mice. J Clin Invest 127(7):2569\u20132585. https:\/\/doi.org\/10.1172\/JCI89607","journal-title":"J Clin Invest"},{"issue":"12","key":"9953_CR175","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.ajpath.2014.08.018","volume":"184","author":"BA Lubeck","year":"2014","unstructured":"Lubeck BA, Lapinski PE, Bauler TJ, Oliver JA, Hughes ED, Saunders TL, King PD (2014) Blood vascular abnormalities in Rasa 1(R780Q) knockin mice: implications for the pathogenesis of capillary malformation-arteriovenous malformation. Am J Pathol 184(12):3163\u20133169. https:\/\/doi.org\/10.1016\/j.ajpath.2014.08.018","journal-title":"Am J Pathol"},{"issue":"6","key":"9953_CR176","doi-asserted-by":"publisher","first-page":"609","DOI":"10.15252\/emmm.201506078","volume":"8","author":"J Korbelin","year":"2016","unstructured":"Korbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, Seismann H, Lampe M, Bannach J, Pasparakis M, Kleinschmidt JA, Schwaninger M, Trepel M (2016) A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med 8(6):609\u2013625. https:\/\/doi.org\/10.15252\/emmm.201506078","journal-title":"EMBO Mol Med"},{"key":"9953_CR177","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-024-09918-8","author":"T Tu","year":"2024","unstructured":"Tu T, Yu J, Jiang C, Zhang S, Li J, Ren J, Zhang S, Zhou Y, Cui Z, Lu H, Meng X, Wang Z, Xing D, Zhang H, Hong T (2024) Somatic Braf(V600E) mutation in the cerebral endothelium induces brain arteriovenous malformations. Angiogenesis. https:\/\/doi.org\/10.1007\/s10456-024-09918-8","journal-title":"Angiogenesis"},{"issue":"4","key":"9953_CR178","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s44161-022-00046-4","volume":"1","author":"T Krolak","year":"2022","unstructured":"Krolak T, Chan KY, Kaplan L, Huang Q, Wu J, Zheng Q, Kozareva V, Beddow T, Tobey IG, Pacouret S, Chen AT, Chan YA, Ryvkin D, Gu C, Deverman BE (2022) A high-efficiency AAV for endothelial cell transduction throughout the central nervous system. Nat Cardiovasc Res 1(4):389\u2013400. https:\/\/doi.org\/10.1038\/s44161-022-00046-4","journal-title":"Nat Cardiovasc Res"},{"issue":"3","key":"9953_CR179","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/HYPERTENSIONAHA.120.15581","volume":"76","author":"MM Santisteban","year":"2020","unstructured":"Santisteban MM, Ahn SJ, Lane D, Faraco G, Garcia-Bonilla L, Racchumi G, Poon C, Schaeffer S, Segarra SG, Korbelin J, Anrather J, Iadecola C (2020) Endothelium-macrophage crosstalk mediates blood-brain barrier dysfunction in hypertension. Hypertension 76(3):795\u2013807. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15581","journal-title":"Hypertension"},{"issue":"1","key":"9953_CR180","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0271678X211039617","volume":"42","author":"H Grasshoff","year":"2022","unstructured":"Grasshoff H, Muller-Fielitz H, Dogbevia GK, Korbelin J, Bannach J, Vahldieck CM, Kusche-Vihrog K, Johren O, Muller OJ, Nogueiras R, Prevot V, Schwaninger M (2022) Short regulatory DNA sequences to target brain endothelial cells for gene therapy. J Cereb Blood Flow Metab 42(1):104\u2013120. https:\/\/doi.org\/10.1177\/0271678X211039617","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"9953_CR181","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1152\/jn.00523.2019","volume":"123","author":"RU Goz","year":"2020","unstructured":"Goz RU, Akgul G, LoTurco JJ (2020) BRAFV600E expression in neural progenitors results in a hyperexcitable phenotype in neocortical pyramidal neurons. J Neurophysiol 123(6):2449\u20132464. https:\/\/doi.org\/10.1152\/jn.00523.2019","journal-title":"J Neurophysiol"},{"issue":"11","key":"9953_CR182","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-018-0172-x","volume":"24","author":"HY Koh","year":"2018","unstructured":"Koh HY, Kim SH, Jang J, Kim H, Han S, Lim JS, Son G, Choi J, Park BO, Heo WD, Han J, Lee HJ, Lee D, Kang HC, Shong M, Paik SB, Kim DS, Lee JH (2018) BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors. Nat Med 24(11):1662\u20131668. https:\/\/doi.org\/10.1038\/s41591-018-0172-x","journal-title":"Nat Med"},{"issue":"3","key":"9953_CR183","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI63034","volume":"123","author":"Y Deng","year":"2013","unstructured":"Deng Y, Atri D, Eichmann A, Simons M (2013) Endothelial ERK signaling controls lymphatic fate specification. J Clin Invest 123(3):1202\u20131215. https:\/\/doi.org\/10.1172\/JCI63034","journal-title":"J Clin Invest"},{"issue":"19","key":"9953_CR184","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1182\/blood-2012-12-474601","volume":"121","author":"Y Deng","year":"2013","unstructured":"Deng Y, Larrivee B, Zhuang ZW, Atri D, Moraes F, Prahst C, Eichmann A, Simons M (2013) Endothelial RAF1\/ERK activation regulates arterial morphogenesis. Blood 121(19):3988\u20133996. https:\/\/doi.org\/10.1182\/blood-2012-12-474601","journal-title":"Blood"},{"issue":"7","key":"9953_CR185","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41591-019-0479-2","volume":"25","author":"D Li","year":"2019","unstructured":"Li D, March ME, Gutierrez-Uzquiza A, Kao C, Seiler C, Pinto E, Matsuoka LS, Battig MR, Bhoj EJ, Wenger TL, Tian L, Robinson N, Wang T, Liu Y, Weinstein BM, Swift M, Jung HM, Kaminski CN, Chiavacci R, Perkins JA, Levine MA, Sleiman PMA, Hicks PJ, Strausbaugh JT, Belasco JB, Dori Y, Hakonarson H (2019) ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Nat Med 25(7):1116\u20131122. https:\/\/doi.org\/10.1038\/s41591-019-0479-2","journal-title":"Nat Med"},{"issue":"8","key":"9953_CR186","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","volume":"20","author":"EE Patton","year":"2021","unstructured":"Patton EE, Zon LI, Langenau DM (2021) Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. Nat Rev Drug Discov 20(8):611\u2013628. https:\/\/doi.org\/10.1038\/s41573-021-00210-8","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9953_CR187","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10456-022-09853-6","volume":"26","author":"PJ Smits","year":"2023","unstructured":"Smits PJ, Sudduth CL, Konczyk DJ, Cheng YS, Vivero MP, Kozakewich HPW, Warman ML, Greene AK (2023) Endothelial cell expression of mutant Map2k1 causes vascular malformations in mice. Angiogenesis 26(1):97\u2013105. https:\/\/doi.org\/10.1007\/s10456-022-09853-6","journal-title":"Angiogenesis"},{"issue":"23","key":"9953_CR188","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","volume":"73","author":"D Lake","year":"2016","unstructured":"Lake D, Correa SA, Muller J (2016) Negative feedback regulation of the ERK1\/2 MAPK pathway. Cell Mol Life Sci 73(23):4397\u20134413. https:\/\/doi.org\/10.1007\/s00018-016-2297-8","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"9953_CR189","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4274\/tjh.galenos.2018.2018.0190","volume":"36","author":"M Baysal","year":"2019","unstructured":"Baysal M, Umit EG, Kirkizlar HO, Ozdover AC, Demir AM (2019) Thalidomide for the management of bleeding episodes in patients with hereditary hemorrhagic telangiectasia: effects on epistaxis severity score and quality of life. Turk J Haematol 36(1):43\u201347. https:\/\/doi.org\/10.4274\/tjh.galenos.2018.2018.0190","journal-title":"Turk J Haematol"},{"issue":"11","key":"9953_CR190","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/S2352-3026(15)00195-7","volume":"2","author":"R Invernizzi","year":"2015","unstructured":"Invernizzi R, Quaglia F, Klersy C, Pagella F, Ornati F, Chu F, Matti E, Spinozzi G, Plumitallo S, Grignani P, Olivieri C, Bastia R, Bellistri F, Danesino C, Benazzo M, Balduini CL (2015) Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study. Lancet Haematol 2(11):e465\u2013e473. https:\/\/doi.org\/10.1016\/S2352-3026(15)00195-7","journal-title":"Lancet Haematol"},{"issue":"22","key":"9953_CR191","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.4103\/0366-6999.169068","volume":"128","author":"HL Peng","year":"2015","unstructured":"Peng HL, Yi YF, Zhou SK, Xie SS, Zhang GS (2015) Thalidomide effects in patients with hereditary hemorrhagic telangiectasia during therapeutic treatment and in Fli-EGFP transgenic zebrafish model. Chin Med J 128(22):3050\u20133054. https:\/\/doi.org\/10.4103\/0366-6999.169068","journal-title":"Chin Med J"},{"issue":"5","key":"9953_CR192","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/STROKEAHA.117.020356","volume":"49","author":"W Zhu","year":"2018","unstructured":"Zhu W, Chen W, Zou D, Wang L, Bao C, Zhan L, Saw D, Wang S, Winkler E, Li Z, Zhang M, Shen F, Shaligram S, Lawton M, Su H (2018) Thalidomide reduces hemorrhage of brain arteriovenous malformations in a mouse model. Stroke 49(5):1232\u20131240. https:\/\/doi.org\/10.1161\/STROKEAHA.117.020356","journal-title":"Stroke"},{"key":"9953_CR193","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s44161-022-00080-2","volume":"1","author":"LM Boon","year":"2022","unstructured":"Boon LM, Dekeuleneer V, Coulie J, Marot L, Bataille A-C, Hammer F, CLapuyt P, Jeanjean A, Dompmartin A, Vikkula M (2022) Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations. Nat Cardiovasc Res 1:562\u2013567. https:\/\/doi.org\/10.1038\/s44161-022-00080-2","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"9953_CR194","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","volume":"14","author":"E Buscarini","year":"2019","unstructured":"Buscarini E, Botella LM, Geisthoff U, Kjeldsen AD, Mager HJ, Pagella F, Suppressa P, Zarrabeitia R, Dupuis-Girod S, Shovlin CL, Vascern HHT (2019) Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis 14(1):28. https:\/\/doi.org\/10.1186\/s13023-018-0982-4","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"9953_CR195","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2012.250","volume":"307","author":"S Dupuis-Girod","year":"2012","unstructured":"Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Riviere S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F (2012) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307(9):948\u2013955. https:\/\/doi.org\/10.1001\/jama.2012.250","journal-title":"JAMA"},{"issue":"11","key":"9953_CR196","doi-asserted-by":"publisher","first-page":"e0188943","DOI":"10.1371\/journal.pone.0188943","volume":"12","author":"A Guilhem","year":"2017","unstructured":"Guilhem A, Fargeton AE, Simon AC, Duffau P, Harle JR, Lavigne C, Carette MF, Bletry O, Kaminsky P, Leguy V, Lerolle N, Roux D, Lambert M, Chinet T, Bonnet D, Dupuis-Girod S, Riviere S (2017) Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): a retrospective study of 46 patients. PLoS ONE 12(11):e0188943. https:\/\/doi.org\/10.1371\/journal.pone.0188943","journal-title":"PLoS ONE"},{"issue":"2","key":"9953_CR197","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2017.11.013","volume":"93","author":"VN Iyer","year":"2018","unstructured":"Iyer VN, Apala DR, Pannu BS, Kotecha A, Brinjikji W, Leise MD, Kamath PS, Misra S, Begna KH, Cartin-Ceba R, DuBrock HM, Krowka MJ, O\u2019Brien EK, Pruthi RK, Schroeder DR, Swanson KL (2018) Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding. Mayo Clin Proc 93(2):155\u2013166. https:\/\/doi.org\/10.1016\/j.mayocp.2017.11.013","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"9953_CR198","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4193\/Rhin18.289","volume":"57","author":"T Rosenberg","year":"2019","unstructured":"Rosenberg T, Fialla AD, Kjeldsen J, Kjeldsen AD (2019) Does severe bleeding in HHT patients respond to intravenous bevacizumab? Review of the literature and case series. Rhinology 57(4):242\u2013251. https:\/\/doi.org\/10.4193\/Rhin18.289","journal-title":"Rhinology"},{"issue":"7","key":"9953_CR199","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1161\/STROKEAHA.111.647982","volume":"43","author":"EJ Walker","year":"2012","unstructured":"Walker EJ, Su H, Shen F, Degos V, Amend G, Jun K, Young WL (2012) Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain. Stroke 43(7):1925\u20131930. https:\/\/doi.org\/10.1161\/STROKEAHA.111.647982","journal-title":"Stroke"},{"issue":"1","key":"9953_CR200","doi-asserted-by":"publisher","first-page":"e000114","DOI":"10.1136\/bmjno-2020-000114","volume":"3","author":"R Muster","year":"2021","unstructured":"Muster R, Ko N, Smith W, Su H, Dickey MA, Nelson J, McCulloch CE, Sneed PK, Clarke JL, Saloner DA, Eisenmenger L, Kim H, Cooke DL (2021) Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation. BMJ Neurol Open 3(1):e000114. https:\/\/doi.org\/10.1136\/bmjno-2020-000114","journal-title":"BMJ Neurol Open"},{"issue":"6","key":"9953_CR201","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/jth.13683","volume":"15","author":"YH Kim","year":"2017","unstructured":"Kim YH, Kim MJ, Choe SW, Sprecher D, Lee YJ, Oh SP (2017) Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia. J Thromb Haemost 15(6):1095\u20131102. https:\/\/doi.org\/10.1111\/jth.13683","journal-title":"J Thromb Haemost"},{"issue":"1","key":"9953_CR202","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10456-018-9646-1","volume":"22","author":"ME Faughnan","year":"2019","unstructured":"Faughnan ME, Gossage JR, Chakinala MM, Oh SP, Kasthuri R, Hughes CCW, McWilliams JP, Parambil JG, Vozoris N, Donaldson J, Paul G, Berry P, Sprecher DL (2019) Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia. Angiogenesis 22(1):145\u2013155. https:\/\/doi.org\/10.1007\/s10456-018-9646-1","journal-title":"Angiogenesis"},{"key":"9953_CR203","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-219393","author":"E Kovacs-Sipos","year":"2017","unstructured":"Kovacs-Sipos E, Holzmann D, Scherer T, Soyka MB (2017) Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2017-219393","journal-title":"BMJ Case Rep"},{"issue":"2","key":"9953_CR204","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1172\/JCI127425","volume":"130","author":"S Ruiz","year":"2020","unstructured":"Ruiz S, Zhao H, Chandakkar P, Papoin J, Choi H, Nomura-Kitabayashi A, Patel R, Gillen M, Diao L, Chatterjee PK, He M, Al-Abed Y, Wang P, Metz CN, Oh SP, Blanc L, Campagne F, Marambaud P (2020) Correcting Smad1\/5\/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models. J Clin Invest 130(2):942\u2013957. https:\/\/doi.org\/10.1172\/JCI127425","journal-title":"J Clin Invest"},{"issue":"24","key":"9953_CR205","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1093\/hmg\/ddx358","volume":"26","author":"S Ruiz","year":"2017","unstructured":"Ruiz S, Chandakkar P, Zhao H, Papoin J, Chatterjee PK, Christen E, Metz CN, Blanc L, Campagne F, Marambaud P (2017) Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology. Hum Mol Genet 26(24):4786\u20134798. https:\/\/doi.org\/10.1093\/hmg\/ddx358","journal-title":"Hum Mol Genet"},{"issue":"8","key":"9953_CR206","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1172\/JCI65592","volume":"123","author":"E Spiekerkoetter","year":"2013","unstructured":"Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, Sawada H, Haghighat R, Chan R, Haghighat L, de Jesus PV, Wang L, Reddy S, Zhao M, Bernstein D, Solow-Cordero DE, Beachy PA, Wandless TJ, Ten Dijke P, Rabinovitch M (2013) FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest 123(8):3600\u20133613. https:\/\/doi.org\/10.1172\/JCI65592","journal-title":"J Clin Invest"},{"issue":"5","key":"9953_CR207","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/ATVBAHA.118.310760","volume":"38","author":"E Alsina-Sanchis","year":"2018","unstructured":"Alsina-Sanchis E, Garcia-Ibanez Y, Figueiredo AM, Riera-Domingo C, Figueras A, Matias-Guiu X, Casanovas O, Botella LM, Pujana MA, Riera-Mestre A, Graupera M, Vinals F (2018) ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation. Arterioscler Thromb Vasc Biol 38(5):1216\u20131229. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310760","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"9953_CR208","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/pbc.26049","volume":"63","author":"R Salloum","year":"2016","unstructured":"Salloum R, Fox CE, Alvarez-Allende CR, Hammill AM, Dasgupta R, Dickie BH, Mobberley-Schuman P, Wentzel MS, Chute C, Kaul A, Patel M, Merrow AC, Gupta A, Whitworth JR, Adams DM (2016) Response of blue rubber bleb nevus syndrome to sirolimus treatment. Pediatr Blood Cancer 63(11):1911\u20131914. https:\/\/doi.org\/10.1002\/pbc.26049","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"9953_CR209","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/08880018.2016.1160170","volume":"33","author":"S Yesil","year":"2016","unstructured":"Yesil S, Tanyildiz HG, Bozkurt C, Cakmakci E, Sahin G (2016) Single-center experience with sirolimus therapy for vascular malformations. Pediatr Hematol Oncol 33(3):219\u2013225. https:\/\/doi.org\/10.3109\/08880018.2016.1160170","journal-title":"Pediatr Hematol Oncol"},{"issue":"Suppl 3","key":"9953_CR210","doi-asserted-by":"publisher","first-page":"e29603","DOI":"10.1002\/pbc.29603","volume":"69","author":"KA Shimano","year":"2022","unstructured":"Shimano KA, Eng W, Adams DM (2022) How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies. Pediatr Blood Cancer 69(Suppl 3):e29603. https:\/\/doi.org\/10.1002\/pbc.29603","journal-title":"Pediatr Blood Cancer"},{"key":"9953_CR211","doi-asserted-by":"publisher","DOI":"10.3171\/2019.7.PEDS1976","author":"K Maynard","year":"2019","unstructured":"Maynard K, LoPresti M, Iacobas I, Kan P, Lam S (2019) Antiangiogenic agent as a novel treatment for pediatric intracranial arteriovenous malformations: case report. J Neurosurg Pediatr. https:\/\/doi.org\/10.3171\/2019.7.PEDS1976","journal-title":"J Neurosurg Pediatr"},{"issue":"9","key":"9953_CR212","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Eklund L, Alitalo K (2017) Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov 16(9):635\u2013661. https:\/\/doi.org\/10.1038\/nrd.2016.278","journal-title":"Nat Rev Drug Discov"},{"issue":"7\u20138","key":"9953_CR213","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cca.2009.12.023","volume":"411","author":"L Ojeda-Fernandez","year":"2010","unstructured":"Ojeda-Fernandez L, Barrios L, Rodriguez-Barbero A, Recio-Poveda L, Bernabeu C, Botella LM (2010) Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT). Clin Chim Acta 411(7\u20138):494\u2013499. https:\/\/doi.org\/10.1016\/j.cca.2009.12.023","journal-title":"Clin Chim Acta"},{"issue":"1","key":"9953_CR214","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10456-013-9383-4","volume":"17","author":"DS Ardelean","year":"2014","unstructured":"Ardelean DS, Jerkic M, Yin M, Peter M, Ngan B, Kerbel RS, Foster FS, Letarte M (2014) Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment. Angiogenesis 17(1):129\u2013146. https:\/\/doi.org\/10.1007\/s10456-013-9383-4","journal-title":"Angiogenesis"},{"issue":"6","key":"9953_CR215","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","volume":"97","author":"SP Oh","year":"2000","unstructured":"Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97(6):2626\u20132631. https:\/\/doi.org\/10.1073\/pnas.97.6.2626","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9953_CR216","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/00006123-200010000-00022","volume":"47","author":"T Hashimoto","year":"2000","unstructured":"Hashimoto T, Emala CW, Joshi S, Mesa-Tejada R, Quick CM, Feng L, Libow A, Marchuk DA, Young WL (2000) Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47(4):910\u2013918. https:\/\/doi.org\/10.1097\/00006123-200010000-00022","journal-title":"Neurosurgery"},{"issue":"2","key":"9953_CR217","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/hh1401.094281","volume":"89","author":"T Hashimoto","year":"2001","unstructured":"Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL (2001) Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 89(2):111\u2013113. https:\/\/doi.org\/10.1161\/hh1401.094281","journal-title":"Circ Res"},{"issue":"6584","key":"9953_CR218","doi-asserted-by":"publisher","first-page":"eabi7377","DOI":"10.1126\/science.abi7377","volume":"375","author":"EA Winkler","year":"2022","unstructured":"Winkler EA, Kim CN, Ross JM, Garcia JH, Gil E, Oh I, Chen LQ, Wu D, Catapano JS, Raygor K, Narsinh K, Kim H, Weinsheimer S, Cooke DL, Walcott BP, Lawton MT, Gupta N, Zlokovic BV, Chang EF, Abla AA, Lim DA, Nowakowski TJ (2022) A single-cell atlas of the normal and malformed human brain vasculature. Science 375(6584):eabi7377. https:\/\/doi.org\/10.1126\/science.abi7377","journal-title":"Science"},{"issue":"8","key":"9953_CR219","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","volume":"102","author":"L David","year":"2008","unstructured":"David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S, Plauchu H, Feige JJ, Bailly S (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102(8):914\u2013922. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.165530","journal-title":"Circ Res"},{"key":"9953_CR220","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.15.554413","author":"S Dinakaran","year":"2023","unstructured":"Dinakaran S, Zhao H, Tang Y, Wang Z, Ruiz S, Nomura-Kitabayashi A, Blanc L, Faughnan ME, Marambaud P (2023) CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia. BioRxiv. https:\/\/doi.org\/10.1101\/2023.09.15.554413","journal-title":"BioRxiv"},{"issue":"12","key":"9953_CR221","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.122.062952","volume":"149","author":"G Genet","year":"2024","unstructured":"Genet G, Genet N, Paila U, Cain SR, Cwiek A, Chavkin NW, Serbulea V, Figueras A, Cerda P, McDonnell SP, Sankaranarayanan D, Huba M, Nelson EA, Riera-Mestre A, Hirschi KK (2024) Induced endothelial cell cycle arrest prevents arteriovenous malformations in hereditary hemorrhagic telangiectasia. Circulation 149(12):944\u2013962. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062952","journal-title":"Circulation"},{"issue":"8","key":"9953_CR222","doi-asserted-by":"publisher","first-page":"e202201685","DOI":"10.26508\/lsa.202201685","volume":"6","author":"BR Acharya","year":"2023","unstructured":"Acharya BR, Fang JS, Jeffery ED, Chavkin NW, Genet G, Vasavada H, Nelson EA, Sheynkman GM, Humphries MJ, Hirschi KK (2023) Connexin 37 sequestering of activated-ERK in the cytoplasm promotes p27-mediated endothelial cell cycle arrest. Life Sci Alliance 6(8):e202201685. https:\/\/doi.org\/10.26508\/lsa.202201685","journal-title":"Life Sci Alliance"},{"issue":"1","key":"9953_CR223","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1038\/s41467-022-33324-7","volume":"13","author":"NW Chavkin","year":"2022","unstructured":"Chavkin NW, Genet G, Poulet M, Jeffery ED, Marziano C, Genet N, Vasavada H, Nelson EA, Acharya BR, Kour A, Aragon J, McDonnell SP, Huba M, Sheynkman GM, Walsh K, Hirschi KK (2022) Endothelial cell cycle state determines propensity for arterial-venous fate. Nat Commun 13(1):5891. https:\/\/doi.org\/10.1038\/s41467-022-33324-7","journal-title":"Nat Commun"},{"issue":"1","key":"9953_CR224","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/s41467-017-01742-7","volume":"8","author":"JS Fang","year":"2017","unstructured":"Fang JS, Coon BG, Gillis N, Chen Z, Qiu J, Chittenden TW, Burt JM, Schwartz MA, Hirschi KK (2017) Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat Commun 8(1):2149. https:\/\/doi.org\/10.1038\/s41467-017-01742-7","journal-title":"Nat Commun"},{"issue":"14","key":"9953_CR225","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","volume":"80","author":"IA Prior","year":"2020","unstructured":"Prior IA, Hood FE, Hartley JL (2020) The frequency of Ras mutations in cancer. Cancer Res 80(14):2969\u20132974. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3682","journal-title":"Cancer Res"},{"issue":"1","key":"9953_CR226","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1128\/MCB.18.1.85","volume":"18","author":"RE Barrington","year":"1998","unstructured":"Barrington RE, Subler MA, Rands E, Omer CA, Miller PJ, Hundley JE, Koester SK, Troyer DA, Bearss DJ, Conner MW, Gibbs JB, Hamilton K, Koblan KS, Mosser SD, O\u2019Neill TJ, Schaber MD, Senderak ET, Windle JJ, Oliff A, Kohl NE (1998) A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol Cell Biol 18(1):85\u201392. https:\/\/doi.org\/10.1128\/MCB.18.1.85","journal-title":"Mol Cell Biol"},{"issue":"8","key":"9953_CR227","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nm0895-792","volume":"1","author":"NE Kohl","year":"1995","unstructured":"Kohl NE, Omer CA, Conner MW, Anthony NJ, Davide JP, deSolms SJ, Giuliani EA, Gomez RP, Graham SL, Hamilton K et al (1995) Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat Med 1(8):792\u2013797. https:\/\/doi.org\/10.1038\/nm0895-792","journal-title":"Nat Med"},{"issue":"9","key":"9953_CR228","first-page":"747","volume":"1","author":"RB Lobell","year":"2002","unstructured":"Lobell RB, Liu D, Buser CA, Davide JP, DePuy E, Hamilton K, Koblan KS, Lee Y, Mosser S, Motzel SL, Abbruzzese JL, Fuchs CS, Rowinsky EK, Rubin EH, Sharma S, Deutsch PJ, Mazina KE, Morrison BW, Wildonger L, Yao SL, Kohl NE (2002) Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I. Mol Cancer Ther 1(9):747\u2013758","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"9953_CR229","first-page":"1253","volume":"58","author":"R Mangues","year":"1998","unstructured":"Mangues R, Corral T, Kohl NE, Symmans WF, Lu S, Malumbres M, Gibbs JB, Oliff A, Pellicer A (1998) Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice. Cancer Res 58(6):1253\u20131259","journal-title":"Cancer Res"},{"issue":"10","key":"9953_CR230","first-page":"2680","volume":"60","author":"CA Omer","year":"2000","unstructured":"Omer CA, Chen Z, Diehl RE, Conner MW, Chen HY, Trumbauer ME, Gopal-Truter S, Seeburger G, Bhimnathwala H, Abrams MT, Davide JP, Ellis MS, Gibbs JB, Greenberg I, Koblan KS, Kral AM, Liu D, Lobell RB, Miller PJ, Mosser SD, O\u2019Neill TJ, Rands E, Schaber MD, Senderak ET, Oliff A, Kohl NE (2000) Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor. Cancer Res 60(10):2680\u20132688","journal-title":"Cancer Res"},{"key":"9953_CR231","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.sbi.2021.06.013","volume":"71","author":"L Herdeis","year":"2021","unstructured":"Herdeis L, Gerlach D, McConnell DB, Kessler D (2021) Stopping the beating heart of cancer: KRAS reviewed. Curr Opin Struct Biol 71:136\u2013147. https:\/\/doi.org\/10.1016\/j.sbi.2021.06.013","journal-title":"Curr Opin Struct Biol"},{"issue":"12","key":"9953_CR232","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41573-020-0089-1","volume":"19","author":"AR Moore","year":"2020","unstructured":"Moore AR, Rosenberg SC, McCormick F, Malek S (2020) Author correction: RAS-targeted therapies: is the undruggable drugged? Nat Rev Drug Discov 19(12):902. https:\/\/doi.org\/10.1038\/s41573-020-0089-1","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"9953_CR233","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","volume":"65","author":"X Wang","year":"2022","unstructured":"Wang X, Allen S, Blake JF, Bowcut V, Briere DM, Calinisan A, Dahlke JR, Fell JB, Fischer JP, Gunn RJ, Hallin J, Laguer J, Lawson JD, Medwid J, Newhouse B, Nguyen P, O\u2019Leary JM, Olson P, Pajk S, Rahbaek L, Rodriguez M, Smith CR, Tang TP, Thomas NC, Vanderpool D, Vigers GP, Christensen JG, Marx MA (2022) Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS(G12D) Inhibitor. J Med Chem 65(4):3123\u20133133. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01688","journal-title":"J Med Chem"},{"issue":"1","key":"9953_CR234","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1038\/s41467-020-17022-w","volume":"11","author":"N Bery","year":"2020","unstructured":"Bery N, Miller A, Rabbitts T (2020) A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS. Nat Commun 11(1):3233. https:\/\/doi.org\/10.1038\/s41467-020-17022-w","journal-title":"Nat Commun"},{"key":"9953_CR235","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddac169","author":"HL Nguyen","year":"2022","unstructured":"Nguyen HL, Boon LM, Vikkula M (2022) Trametinib as a promising therapeutic option in alleviating vascular defects in an endothelial KRAS-induced mouse model. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddac169","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9953_CR236","doi-asserted-by":"publisher","first-page":"e018","DOI":"10.1097\/jova.0000000000000018","volume":"2","author":"DL Cooke","year":"2021","unstructured":"Cooke DL, Frieden IJ, Shimano KA (2021) Angiographic evidence of response to trametinib therapy for a spinal cord arteriovenous malformation. J Vasc Anomalies 2(3):e018. https:\/\/doi.org\/10.1097\/jova.0000000000000018","journal-title":"J Vasc Anomalies"},{"key":"9953_CR237","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3206","author":"EA Edwards","year":"2020","unstructured":"Edwards EA, Phelps AS, Cooke D, Frieden IJ, Zapala MA, Fullerton HJ, Shimano KA (2020) Monitoring arteriovenous malformation response to genotype-targeted therapy. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2019-3206","journal-title":"Pediatrics"},{"issue":"2","key":"9953_CR238","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamadermatol.2018.4653","volume":"155","author":"R Lekwuttikarn","year":"2019","unstructured":"Lekwuttikarn R, Lim YH, Admani S, Choate KA, Teng JMC (2019) Genotype-guided medical treatment of an arteriovenous malformation in a child. JAMA Dermatol 155(2):256\u2013257. https:\/\/doi.org\/10.1001\/jamadermatol.2018.4653","journal-title":"JAMA Dermatol"},{"issue":"2","key":"9953_CR239","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/pde.14912","volume":"39","author":"CL Nicholson","year":"2022","unstructured":"Nicholson CL, Flanagan S, Murati M, Boull C, McGough E, Ameduri R, Weigel B, Maguiness S (2022) Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromise. Pediatr Dermatol 39(2):316\u2013319. https:\/\/doi.org\/10.1111\/pde.14912","journal-title":"Pediatr Dermatol"},{"key":"9953_CR240","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07493-y","author":"T Walchli","year":"2024","unstructured":"Walchli T, Ghobrial M, Schwab M, Takada S, Zhong H, Suntharalingham S, Vetiska S, Gonzalez DR, Wu R, Rehrauer H, Dinesh A, Yu K, Chen ELY, Bisschop J, Farnhammer F, Mansur A, Kalucka J, Tirosh I, Regli L, Schaller K, Frei K, Ketela T, Bernstein M, Kongkham P, Carmeliet P, Valiante T, Dirks PB, Suva ML, Zadeh G, Tabar V, Schlapbach R, Jackson HW, De Bock K, Fish JE, Monnier PP, Bader GD, Radovanovic I (2024) Single-cell atlas of the human brain vasculature across development, adulthood and disease. Nature. https:\/\/doi.org\/10.1038\/s41586-024-07493-y","journal-title":"Nature"},{"issue":"16","key":"9953_CR241","doi-asserted-by":"publisher","first-page":"e1637","DOI":"10.1212\/WNL.0000000000200109","volume":"98","author":"E Winkler","year":"2022","unstructured":"Winkler E, Wu D, Gil E, McCoy D, Narsinh K, Sun Z, Mueller K, Ross J, Kim H, Weinsheimer S, Berger M, Nowakowski T, Lim D, Abla A, Cooke D (2022) Endoluminal biopsy for molecular profiling of human brain vascular malformations. Neurology 98(16):e1637\u2013e1647. https:\/\/doi.org\/10.1212\/WNL.0000000000200109","journal-title":"Neurology"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-024-09953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-024-09953-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-024-09953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T10:31:03Z","timestamp":1748687463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-024-09953-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":241,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["9953"],"URL":"https:\/\/doi.org\/10.1007\/s10456-024-09953-5","relation":{},"ISSN":["1573-7209"],"issn-type":[{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"15"}}